Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 1-13445

Sonida Senior Living, Inc.

(Exact Name of Registrant as Specified in its Charter)


Delaware						75-2678809
(State or Other Jurisdiction of Incorporation or Organization)						(I.R.S. Employer Identification No.)


14755 Preston Road, Suite 810, Dallas, Texas						75254
(Address of principal executive offices)						(Zip code)

(972) 770-5600

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading
Symbol(s)

Name of exchange on which registered

Common Stock, $0.01 par value per share

SNDA

New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by a check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No x

As of May 8, 2024, the Registrant had 13,854,520 shares of common stock outstanding.

Sonida Senior Living, Inc.

Form 10-Q Table of Contents

For the Period Ended March 31, 2024


			Page Number
Part I. Financial Information
Item 1. Financial Statements
Condensed Consolidated Balance Sheets — March 31, 2024 (Unaudited) and December 31, 2023			4
Condensed Consolidated Statements of Operations — Three Months Ended March 31, 2024 and 2023 (Unaudited)			5
Condensed Consolidated Statements of Shareholders’ Equity (Deficit)— Three Months Ended March 31, 2024 and 2023 (Unaudited)			6
Condensed Consolidated Statements of Cash Flows — Three Months Ended March 31, 2024 and 2023 (Unaudited)			7
Notes to Condensed Consolidated Financial Statements (Unaudited)			8
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations			24
Item 3. Quantitative and Qualitative Disclosures About Market Risk			29
Item 4. Controls and Procedures			30
Part II. Other Information			31
Item 1. Legal Proceedings			31
Item 1A. Risk Factors			31
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds			31
Item 3. Defaults Upon Senior Securities			31
Item 4. Mine Safety Disclosures			31
Item 5. Other Information			31
Item 6. Exhibits			31
Signature			33

Cautionary Note Regarding Forward-Looking Statements

Certain information contained in this Quarterly Report on Form 10-Q of Sonida Senior Living, Inc. (together with its consolidated subsidiaries, “Sonida,” “we,” “our,” “us,” or the “Company”) constitutes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts included in this Quarterly Report on Form 10-Q, including, without limitation, those relating to the Company’s future business prospects and strategies, financial results, working capital, liquidity, capital needs and expenditures, interest costs, insurance availability and contingent liabilities, are forward-looking statements. Forward-looking statements can be identified by the use of forward-looking terminology such as “may,” “will,” “would,” “intend,” “could,” “believe,” “expect,” “anticipate,” “project,” “plans,” “estimate” or “continue” or the negatives thereof or other variations thereon or comparable terminology.

Forward-looking statements are subject to certain risks and uncertainties that could cause the Company’s actual results and financial condition to differ materially from those indicated in the forward-looking statements, including, among others, the risks, uncertainties and factors set forth under “Item. 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities and Exchange Commission (the “SEC”) on March 27, 2024, as well as “Item. 1A. Risk Factors” in this Quarterly Report on Form 10-Q, and also include the following:

•the Company’s ability to generate sufficient cash flows from operations, additional proceeds from equity issuances and debt financings, and proceeds from the sale of assets to satisfy its short- and long-term debt obligations and to fund the Company’s acquisitions and capital improvement projects to expand, redevelop, and/or reposition its senior living communities;

•increases in market interest rates that increase the cost of certain of our debt obligations;

•increased competition for, or a shortage of, skilled workers, including due to general labor market conditions, along with wage pressures resulting from such increased competition, low unemployment levels, use of contract labor, minimum wage increases and/or changes in overtime laws;

•the Company’s ability to obtain additional capital on terms acceptable to it;

•the Company’s ability to extend or refinance its existing debt as such debt matures;

•the Company’s compliance with its debt agreements, including certain financial covenants, and the risk of cross-default in the event such non-compliance occurs;

•the Company’s ability to complete acquisitions and dispositions upon favorable terms or at all;

•the risk of oversupply and increased competition in the markets which the Company operates;

•the Company’s ability to improve and maintain controls over financial reporting and remediate the identified material weakness discussed in Item 4 of Part I of this Quarterly Report on Form 10-Q;

•the cost and difficulty of complying with applicable licensure, legislative oversight, or regulatory changes;

•risks associated with current global economic conditions and general economic factors such as inflation, the consumer price index, commodity costs, fuel and other energy costs, competition in the labor market, costs of salaries, wages, benefits, and insurance, interest rates, and tax rates;

•the impact from or the potential emergence and effects of a future epidemic, pandemic, outbreak of infectious disease or other health crisis; and

•changes in accounting principles and interpretations.

We caution you that the risks, uncertainties and other factors referenced above may not contain all of the risks, uncertainties and other factors that are important to you. In addition, we cannot assure you that we will realize the results, benefits or outcomes that we expect or anticipate or, even if substantially realized, that they will result in the consequences or affect us or our business in the way expected. All forward-looking statements in this Quarterly Report on Form 10-Q apply only as of the date made and are expressly qualified in their entirety by the cautionary statements included in this Quarterly Report on Form 10-Q. Except as required by applicable law, we undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise.

Part I. FINANCIAL INFORMATION

Item 1. Financial Statements

Sonida Senior Living, Inc.

Condensed Consolidated Balance Sheets

(in thousands, except per share amounts)


	March 31, 2024		December 31, 2023
	(Unaudited)
Assets
Current assets:
Cash and cash equivalents	$	24,211	$	4,082
Restricted cash	13,452		13,668
Accounts receivable, net	10,346		8,017

Prepaid expenses and other assets	3,412		4,475
Derivative assets	2,130		2,103
Total current assets	53,551		32,345
Property and equipment, net	581,902		588,179

Other assets, net	824		936
Total assets	$	636,277	$	621,460
Liabilities and Equity
Current liabilities:
Accounts payable	$	4,864	$	11,375
Accrued expenses	39,747		42,388
Current portion of notes payable, net of deferred loan costs	6,831		42,323
Deferred income	4,255		4,041
Federal and state income taxes payable	288		215
Other current liabilities	512		519



Total current liabilities	56,497		100,861
Notes payable, net of deferred loan costs and current portion	571,267		587,099
Other long-term liabilities	40		49
Total liabilities	627,804		688,009
Commitments and contingencies (Note 11)
Redeemable preferred stock:
Series A convertible preferred stock, $0.01 par value; 41 shares authorized, 41 shares issued and outstanding as of March 31, 2024 and December 31, 2023	49,877		48,542
Shareholders’ deficit:
Preferred stock, $0.01 par value:
Authorized shares - 15,000 as of March 31, 2024 and December 31, 2023; none issued or outstanding, except Series A convertible preferred stock as noted above	—		—
Common stock, $0.01 par value:
Authorized shares - 30,000 and 15,000 as of March 31, 2024 and December 31, 2023, respectively; 13,197 and 8,178 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	132		82
Additional paid-in capital	349,610		302,992
Retained deficit	(391,146)		(418,165)
Total shareholders’ deficit	(41,404)		(115,091)
Total liabilities, redeemable preferred stock and shareholders’ deficit	$	636,277	$	621,460

See Notes to Condensed Consolidated Financial Statements.

Sonida Senior Living, Inc.

Condensed Consolidated Statements of Operations (Unaudited)

(in thousands, except per share data)


	Three Months Ended March 31,
		2024		2023
Revenues:
Resident revenue		$	60,737	$	56,606
Management fees		594		505
Managed community reimbursement revenue		6,107		4,962
Total revenues		67,438		62,073
Expenses:
Operating expense		46,317		43,808
General and administrative expense		7,211		7,063

Depreciation and amortization expense		9,935		9,881

Managed community reimbursement expense		6,107		4,962
Total expenses		69,570		65,714
Other income (expense):
Interest income		139		194
Interest expense		(8,591)		(8,867)


Gain on extinguishment of debt, net		38,148		36,339

Other income (expense), net		(479)		189
Income before provision for income taxes		27,085		24,214
Provision for income taxes		(66)		(69)
Net income		27,019		24,145

Undeclared dividends on Series A convertible preferred stock		(1,335)		(1,198)
Undistributed net income allocated to participating securities		(2,849)		(3,182)
Net income attributable to common stockholders		$	22,835	$	19,765

Weighted average common shares outstanding — basic		9,861		6,855
Weighted average common shares outstanding — diluted		10,562		7,168

Basic net income per common share		$	2.32	$	2.88
Diluted net income per common share		$	2.16	$	2.76

See Notes to Condensed Consolidated Financial Statements.

Sonida Senior Living, Inc.

Condensed Consolidated Statements of Shareholders’ Equity (Deficit) (Unaudited)

(in thousands)


	Common Stock			Additional Paid-In Capital		Retained Deficit
	Shares	Amount						Total
Balance as of December 31, 2022	6,670	$	67	$	295,277	$	(397,058)	$	(101,714)
Undeclared dividends on Series A convertible preferred stock	—	—		(1,198)		—		(1,198)
Stock-based plan activity	272	2		(17)		—		(15)
Non-cash stock-based compensation	—	—		902		—		902
Net income	—	—		—		24,145		24,145
Balance as of March 31, 2023	6,942	69		294,964		(372,913)		(77,880)











	Common Stock			Additional Paid-In Capital		Retained Deficit
	Shares	Amount						Total
Balance as of December 31, 2023	8,178	$	82	$	302,992	$	(418,165)	$	(115,091)
Issuance of common stock, net (1)	5,026	50		47,591		—		47,641
Undeclared dividends on Series A convertible preferred stock	—	—		(1,335)		—		(1,335)
Stock-based plan activity	(7)	—		(213)		—		(213)
Non-cash stock-based compensation	—	—		575		—		575

Net income	—	—		—		27,019		27,019
Balance as of March 31, 2024	13,197	132		349,610		(391,146)		(41,404)

__________

(1) Issuance of common stock, net includes the shares of common stock with the Company’s recently completed private placement transaction, net of issuance costs.

See Notes to Condensed Consolidated Financial Statements.

Sonida Senior Living, Inc.

Condensed Consolidated Statements of Cash Flows (Unaudited)

(in thousands)


	Three Months Ended March 31,
	2024		2023
Cash flows from operating activities:
Net income	$	27,019	$	24,145
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	9,935		9,881
Amortization of deferred loan costs	324		366


Gain on sale of assets, net	(192)		(251)


Loss on derivative instruments, net	527		572
Gain on extinguishment of debt	(38,148)		(36,339)
Provision for bad debt	397		237
Non-cash stock-based compensation expense	575		902
Other non-cash items	(3)		(1)
Changes in operating assets and liabilities:
Accounts receivable, net	(2,726)		(48)

Prepaid expenses and other assets	1,063		1,159
Other assets, net	(41)		62
Accounts payable and accrued expense	(3,123)		1,828

Federal and state income taxes payable	73		260
Deferred income	214		438

Other current liabilities	1		38
Net cash provided by (used in) operating activities	(4,105)		3,249
Cash flows from investing activities:

Capital expenditures	(5,762)		(5,429)
Proceeds from sale of assets	631		343
Net cash used in investing activities	(5,131)		(5,086)
Cash flows from financing activities:
Proceeds from notes payable	24,830		—
Repayments of notes payable	(41,999)		(3,714)

Proceeds from issuance of common stock, net	47,641		—

Purchase of interest rate cap	(554)		—
Deferred loan costs paid	(549)		—
Other financing costs	(220)		(45)
Net cash provided by (used in) financing activities	29,149		(3,759)
Increase (decrease) in cash and cash equivalents and restricted cash	19,913		(5,596)
Cash, cash equivalents, and restricted cash at beginning of period	17,750		30,742
Cash, cash equivalents, and restricted cash at end of period	$	37,663	$	25,146

Supplemental Disclosures of Cash Flow Information
Cash paid during the period for:
Interest	$	6,353	$	7,639
Income taxes paid (refunds received), net	$	(7)	$	(193)
Non-cash investing and financing activities:
Undeclared dividends on Series A convertible preferred stock	$	1,335	$	1,198
Non-cash additions of property and equipment	$	498	$	1,150

See Notes to Condensed Consolidated Financial Statements.

Sonida Senior Living, Inc.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

1. Basis of Presentation

Organization and Business

Sonida Senior Living, Inc. (formerly known as Capital Senior Living Corporation), a Delaware corporation (together with its subsidiaries, the “Company,” “we,” “our,” “us,” or “Sonida”), is one of the leading owner-operators of senior housing communities in the United States in terms of resident capacity. The Company owns, operates, and manages senior housing communities throughout the United States. As of March 31, 2024, the Company operated 71 senior housing communities in 18 states with an aggregate capacity of approximately 8,000 residents, including 61 communities which the Company owned and 10 communities that the Company third-party manages. The accompanying condensed consolidated financial statements include the financial statements of Sonida Senior Living, Inc. and its wholly-owned subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation.

Interim Unaudited Financial Information

The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and should be read in conjunction with the condensed consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2023. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted from this Quarterly Report on Form 10-Q pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The results for the interim periods shown in this report are not necessarily indicative of future financial results. The accompanying condensed consolidated financial statements have not been audited by our independent registered public accounting firm. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, including normal recurring items, necessary to present fairly our condensed consolidated financial position as of March 31, 2024 and December 31, 2023, and our condensed consolidated results of operations and cash flows for the periods ended March 31, 2024 and 2023.

Reclassifications

Certain amounts previously reflected in the prior year condensed consolidated financial statements have been reclassified to conform to our March 31, 2024 presentation.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. These estimates include such items related to the accounting for: income taxes, including assessments of probabilities of realization of income tax benefits; impairment of long-lived assets, including applicable cash flow projections, holding periods and fair value evaluations; self-insurance liabilities and expense; stock-based compensation; and depreciation and amortization including determination of estimated useful lives. Actual results could differ from those estimates.

2. Liquidity

During 2023, the Company's liquidity conditions, including operating losses and net working capital deficits, raised substantial doubt about the Company's ability to continue as a going concern. As a result of increases in occupancy occurring throughout 2023 and continuing into 2024, rental rate increases in March 2024 and the 2024 private placement transaction and Protective Life loan purchase, the Company has substantially improved its liquidity position. See “Note 6 –Notes Payable” and “Note 7 –S ecurities Fi nancing” for details of the transactions that have increased cash on hand significantly. In addition, $10.3 million was raised in April 2024 through our at-the-market equity offering. See “Note 15 –Sub sequent Events.” Based on these events, the Company concluded it has adequate cash to meet its obligations as they become due for the 12-month period following the date the March 31, 2024 financial statements are issued.

3. Summary of Significant Accounting Policies

Cash, Cash Equivalents, and Restricted Cash

The Company considers all highly liquid investments with original maturities of three months or less at the date of acquisition to be cash equivalents. The Company has deposits in banks that exceed Federal Deposit Insurance Corporation insurance limits. Management believes that credit risk related to these deposits is minimal. Restricted cash consists of reserve accounts for property insurance, real estate taxes, capital expenditures, derivatives, and debt service required by certain loan agreements. In addition, restricted cash includes deposits required by certain counterparties as collateral pursuant to letters of credit which must remain so long as the letters of credit are outstanding, which are subject to renewal annually.

The following table sets forth our cash, cash equivalents, and restricted cash (in thousands):


	March 31, 2024		December 31, 2023
Cash and cash equivalents	$	24,211	$	4,082
Restricted cash:
Property tax and insurance reserves	5,339		7,237
Lender reserves	4,665		3,329
Capital expenditures reserves	2,714		2,060
Escrow deposit	500		1,000
Deposits pursuant to outstanding letters of credit	42		42
Other reserves	192		—
Total restricted cash	13,452		13,668
Total cash, cash equivalents, and restricted cash	$	37,663	$	17,750

Long-Lived Assets

Property and equipment are stated at cost and depreciated on a straight-line basis over the estimated useful lives of the assets. At each balance sheet date, the Company reviews the carrying value of its property and equipment to determine if facts and circumstances suggest that they may be impaired or that the depreciation period may need to be changed. The Company considers internal factors such as net operating losses along with external factors relating to each asset, including contract changes, local market developments, and other publicly available information to determine whether impairment indicators exist.

If an indicator of impairment is identified, recoverability of an asset group is assessed by comparing its carrying amount to the estimated future undiscounted net cash flows expected to be generated by the asset group through operation or disposition, calculated utilizing the lowest level of identifiable cash flows. If this comparison indicates that the carrying amount of an asset group is not recoverable, the Company estimates fair value of the asset group and records an impairment loss when the carrying amount exceeds fair value. There were no impairments on long-lived assets during the three months ended March 31, 2024 and 2023.

In evaluating our long-lived assets for impairment, we undergo continuous evaluations of property level performance and real estate trends, and management makes several estimates and assumptions, including, but not limited to, the projected date of disposition, estimated sales price, and future cash flows of each property during our estimated holding period. If our analysis or assumptions regarding the projected cash flows expected to result from the use and eventual disposition of our properties change, we incur additional costs and expenses during the holding period, or our expected hold periods change, we may incur future impairment losses.

Upon the acquisition of new communities accounted for as an acquisition of assets, we recognize the assets acquired and the liabilities assumed as of the acquisition date, measured at their relative fair values once we have determined the fair value of each of these assets and liabilities. The acquisition date is the date on which we obtain control of the real estate property. The assets acquired and liabilities assumed consist of land, inclusive of associated rights, buildings, assumed debt, and identified intangible assets and liabilities. See “Note 4–Property and Equipment, net.”

Revenue Recognition

Resident revenue consists of fees for basic housing and certain support services and fees associated with additional housing and expanded support requirements such as assisted living care, memory care, and ancillary services. Basic housing and certain support services revenue is recorded when services are rendered, and amounts billed are due from residents in the period in which the rental and other services are provided. Residency agreements are generally short term in nature with durations of one year or less and are typically terminable by either party, under certain circumstances, upon providing 30 days’ notice, unless state law provides otherwise, with resident fees billed monthly in advance. Revenue for certain ancillary services is recognized as services are provided, and includes fees for services such as medication management, daily living activities, beautician/barber, laundry, television, guest meals, pets, and parking, which are generally billed monthly in arrears. Other operating revenue consists of state relief funds received from various states due to the financial distress impacts of COVID-19 (“State Relief Funds”).

The Company’s senior housing communities have residency agreements that generally require the resident to pay a community fee and other amounts prior to moving into the community, which are initially recorded by the Company as deferred revenue. The Company had contract liabilities for deferred fees paid by our residents prior to the month housing and support services were to be provided totaling approximately $4.3 million and $4.0 million, respectively, which is reported as deferred income within current liabilities of the Company’s condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023.

Revenues from the Medicaid program accounted for 11.6% and 9.3% of the Company’s revenue in the three months ended March 31, 2024 and 2023, respectively. During the three months ended March 31, 2024 and 2023, 22 and 24, respectively, of the Company’s communities were providers of services under the Medicaid program. Accordingly, these communities were entitled to reimbursement under the Medicaid program at established rates that were lower than private pay rates. Resident revenues for Medicaid residents were recorded at the reimbursement rates as the rates were set prospectively by the applicable state upon the filing of an annual cost report. None of the Company’s communities were providers of services under the Medicare program during the three months ended March 31, 2024 and 2023.

Laws and regulations governing the Medicaid program are complex and subject to interpretation. The Company believes that it is in compliance with all applicable laws and regulations and is not aware of any pending or threatened investigations involving allegations of potential wrongdoing that would have a material effect on its Condensed Consolidated Financial Statements. While no such regulatory inquiries have been made, compliance with such laws and regulations can be subject to future government review and interpretation as well as significant regulatory action including fines, penalties, and exclusion from the Medicaid program.

The Company has management agreements whereby it manages certain communities on behalf of third-party owners under contracts that provide for periodic management fee payments to the Company. The Company has determined that all community management activities are a single performance obligation, which is satisfied over time as the services are rendered. The Company’s estimate of the transaction price for management services also includes the amount of reimbursement due from the owners of the communities for services provided and related costs incurred. Such revenue is included in “managed community reimbursement revenue” on the Company’s condensed consolidated statements of operations. The related costs are included in “managed community reimbursement expense” on the Company’s condensed consolidated statements of operations. See “Note 8–Revenue.”

For the three months ended March 31, 2023, the Company received approximately $2.0 million in various State Relief Funds from state departments due to financial distress impacts of COVID-19. For the three months ended March 31, 2024, no State Relief Funds were received from the state departments. The Company recognizes income for government grants on a systematic and rational basis over the periods in which the Company recognizes the related expenses or loss of revenue for which the grants are intended to compensate when there is reasonable assurance that the Company will comply with the applicable terms and conditions of the grant and there is reasonable assurance that the grant will be received. The State Relief Funds were recorded as “resident revenue–other operating revenue” in the Company’s condensed statements of operations and notes thereto.

Credit Risk and Allowance for Doubtful Accounts

The Company’s resident accounts receivable are generally due within 30 days after the date billed. Accounts receivable are reported net of an allowance for doubtful accounts of $5.7 million and $5.3 million as of March 31, 2024 and December 31, 2023, respectively, and represent the Company’s estimate of the amount that ultimately will be collected. The adequacy of the Company’s allowance for doubtful accounts is reviewed on an ongoing basis, using historical payment trends, write-off experience, analyses of receivable portfolios by payor source and aging of receivables, as well as a review of specific accounts, and adjustments are made to the allowance, as necessary. Credit losses on resident receivables have historically been within management’s estimates, and management believes that the allowance for doubtful accounts adequately provides for expected losses.

Concentration of Credit Risk and Business Risk

Substantially all of our revenues are derived from senior living communities we own and senior living communities that we manage. Senior living operations are particularly sensitive to adverse economic, social and competitive conditions and trends, including the effects of the COVID-19 pandemic, which has adversely affected, and may continue to adversely affect, our business, financial condition, and results of operations.

We have a concentration of owned properties operating in Texas (16), Indiana (12), Ohio (10) and Wisconsin (8), which we estimate represented approximately 23%, 19%, 20% and 10%, respectively, of our resident revenues for the three months ended March 31, 2024.

Self-Insurance Liability Accruals

The Company offers full-time employees an option to participate in its health and dental plans. The Company is self-insured up to certain limits and is insured if claims in excess of these limits are incurred. The cost of employee health and dental benefits, net of employee contributions, is shared between the corporate office and the senior housing communities based on the respective number of plan participants. Funds collected are used to pay the actual program costs, including estimated annual claims, third-party administrative fees, network provider fees, communication costs, and other related administrative costs incurred by the plans. Claims are paid as they are submitted to the Company’s third-party administrator. The Company records a liability for outstanding claims and claims that have been incurred but not yet reported. This liability is based on the historical claim reporting lag and payment trends of health insurance claims. Management believes that the recorded liabilities and reserves established for outstanding losses and expenses are adequate to cover the ultimate cost of losses and expenses incurred as of March 31, 2024. It is possible that actual claims and expenses may differ from established reserves. Any subsequent changes in estimates are recorded in the period in which they are determined.

The Company uses a combination of insurance and self-insurance for workers’ compensation. Determining the reserve for workers’ compensation losses and costs that the Company has incurred as of the end of a reporting period involves significant judgments based on projected future events, including among other factors, potential settlements for pending claims, known incidents which may result in claims, estimates of incurred but not yet reported claims, changes in insurance premiums and estimated litigation costs. The Company regularly adjusts these estimates to reflect changes in the foregoing factors. However, since this reserve is based on estimates, it is possible the actual expenses incurred may differ from the amounts reserved. Any subsequent changes in estimates are recorded in the period in which they are determined.

Income Taxes

Income taxes are computed using the asset and liability method and current income taxes are recorded based on amounts refundable or payable in the current year. The effective tax rates for the three months ended March 31, 2024 and 2023 differ from the statutory tax rates due to state income taxes, permanent tax differences, and changes in the deferred tax asset valuation allowance.

Deferred income taxes are recorded based on the estimated future tax effects of loss carryforwards and temporary differences between financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates that are expected to apply to taxable income in the years in which the Company expects those carryforwards and temporary differences to be recovered or settled. Management regularly evaluates the future realization of deferred tax assets and provides a valuation allowance, if considered necessary, based on such evaluation. As part of the evaluation, management has evaluated taxable income in carryback years, future reversals of taxable temporary differences, feasible tax planning strategies, and future expectations of income. The valuation allowance reduces the Company’s net deferred tax assets to the amount that is “more likely than not” (i.e., a greater than 50% likelihood) to be realized. However, in the event that the Company were to ultimately determine that it would be more likely than not that the Company would realize the benefit of deferred tax assets in the future in excess of their net recorded amounts, adjustments to deferred tax assets would increase net income in the period such determination was made. The benefits of the net deferred tax assets might not be realized if actual results differ from expectations.

The Company evaluates uncertain tax positions through consideration of accounting and reporting guidance on criteria, measurement, derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition that is intended to provide better financial statement comparability among different companies. The Company is required to recognize a tax benefit in its financial statements for an uncertain tax position only if management’s assessment is that its position is “more likely than not” (i.e., a greater than 50 percent likelihood) to be upheld on audit based only on the technical merits of the tax position. The Company’s policy is to recognize interest related to unrecognized tax benefits as interest expense and penalties as income tax expense.

The Company filed for an employee retention credit (“ERC”) with the Internal Revenue Service in November 2023. The ERC is a tax credit for businesses that had employees and were affected during the COVID-19 pandemic. We have not received any funds from the ERC as of March 31, 2024.

The Company is evaluating the potential tax impact of the Protective Life Insurance Company gain on extinguishment of debt totaling $38.1 million.

Redeemable Preferred Stock

The Company's Series A Preferred Stock is convertible outside of our control and is classified as mezzanine equity. The Series A Preferred Stock was initially recorded at fair value upon issuance, net of issuance costs and discounts. The holders, or Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP (together, the “Conversant Preferred Investors”), of Series A Preferred Stock are entitled to vote with the holders of common stock on all matters submitted to a vote of stockholders of the Company. As such, the Conversant Preferred Investors, in combination with their common stock ownership as of March 31, 2024 and December 31, 2023, have voting rights in excess of 50% of the Company’s total voting stock. It is deemed probable that the Series A Preferred Stock could be redeemed for cash by the Conversant Preferred Investors, and as such, the Series A Preferred Stock is required to be remeasured and adjusted to its maximum redemption value at the end of each reporting period. However, to the extent that the maximum redemption value of the Series A Preferred Stock does not exceed the fair value of the shares at the date of issuance, the shares are not adjusted below the fair value at the date of issuance. As of March 31, 2024 and December 31, 2023, the Series A Preferred Stock is carried at the maximum redemption value. The Series A Preferred Stock does not have a maturity date and, therefore, is considered perpetual.

Dividends on redeemable Series A Preferred Stock are recorded to retained earnings or additional paid-in capital if retained earnings is an accumulated deficit. Dividends are cumulative, and any declaration of dividends is at the discretion of the Company’s Board of Directors (the “Board”). If the Board does not declare a dividend in respect of any dividend payment date, the amount of such accrued and unpaid dividend is added to the liquidation preference of the Series A Preferred Stock and compounds quarterly thereafter. During the three months ended March 31, 2024, the Board did not declare any dividends with respect to the Series A Preferred Stock, and accordingly, an aggregate of $1.3 million was added to the liquidation preference of the Series A Preferred Stock during such period, effectively increasing the carrying value of the redeemable preferred stock.

Derivative Instruments

We use derivative instruments as part of our overall strategy to manage our exposure to market risks associated with the fluctuations in interest rates. We are also required to enter into interest rate derivative instruments in compliance with certain debt agreements. We regularly monitor the financial stability and credit standing of the counterparties to our derivative instruments. We do not enter into derivative financial instruments for trading or speculative purposes. We record all derivatives at fair value. As of March 31, 2024 and December 31, 2023, our derivative instruments consisted of interest rate caps that were not designated as hedge instruments. Changes in fair value of undesignated hedge instruments are recorded in current period earnings as interest expense. See “Note 14–Derivatives and Hedging.”

Net Income Per Common Share

The Company uses the two-class method to compute net income per common share because the Company has issued securities (Series A Preferred Stock) that entitle the holder to participate in dividends and earnings of the Company. Under this method, net income is reduced by the amount of any dividends earned during the period. The remaining earnings (undistributed earnings) are allocated based on the weighted-average shares outstanding of common stock and Series A Preferred Stock (on an if-converted basis) to the extent that each preferred security may share in earnings as if all of the earnings for the period had been distributed. The total earnings allocated to common stock is then divided by the number of outstanding shares to which the earnings are allocated to determine the earnings per share. The two-class method is not applicable during periods with a net loss, as the holders of the Series A Preferred Stock have no obligation to fund losses.

Diluted net income per common share is computed under the two-class method by using the weighted-average number of shares of common stock outstanding, plus, for periods with net income attributable to common stockholders, the potential dilutive effects of stock options, stock-based compensation awards, and warrants. In addition, the Company analyzes the potential dilutive effect of the outstanding Series A Preferred Stock under the "if-converted" method when calculating diluted earnings per share, in which it is assumed that the outstanding Series A Preferred Stock converts into common stock at the beginning of the period or when issued, if later. The Company reports the more dilutive of the approaches (two class or "if-converted") as its diluted net income per share during the period. See “Note 9 –Net Income Per Share.”

Segment Reporting

The Company evaluates the performance and allocates resources of its senior living communities based on current operations and market assessments on a property-by-property basis. The Company does not have a concentration of operations geographically or by product or service as its management functions are integrated at the property level. The Company has determined that its operating units meet the criteria in Accounting Standards Codification (“ASC”) Topic 280, Segment Reporting, to be aggregated into one reporting segment. As such, the Company operates in one segment.

Troubled Debt Restructurings

The Company assesses all loan modifications with existing lenders to determine if it is a troubled debt restructuring. A loan that has been modified or renewed is considered to be a troubled debt restructuring when two conditions are met: (1) the borrower is experiencing financial difficulty and (2) concessions are made for the borrower’s benefit that would not otherwise be considered for a borrower or a transaction with similar credit risk characteristics. These concessions may include modifications of the terms of the debt such as deferral of payments, extension of maturity, reduction of principal balance, reduction of the stated interest rate other than normal market rate adjustments, or a combination of these concessions. The Company compares the total cash outflows of the restructured debt to the carrying amount of the debt prior to the restructure. If cash outflows of the restructured debt are less than the carrying amount, a gain is recognized and the carrying amount of the debt is adjusted. If cash outflows of the restructured debt are more than the carrying amount, no gain or loss is recognized and the carrying amount of the debt is not adjusted. The change in cash outflows resulting from the restructuring is accounted for on a prospective basis by calculating a new effective interest rate on the restructured debt and applying it to recognize lower interest expense over the remaining term. See “Note 6–Notes Payable.”

Recently Issued Accounting Pronouncements Not Yet Adopted

Improvements to Reportable Segment Disclosures

In November of 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments are intended to increase reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. The ASU is effective on a retrospective basis for fiscal years beginning after December 15, 2023, and interim periods

within fiscal years beginning after December 15, 2024. We are currently evaluating the impact of this guidance on the disclosures within the Company's condensed consolidated financial statements.

Improvements to Income Tax Disclosures

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments require disclosure of specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold and further disaggregation of income taxes paid for individually significant jurisdictions. The ASU is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. We are currently evaluating the impact that this guidance will have on the disclosures within the Company's condensed consolidated financial statements.

4. Property and Equipment, net

As of March 31, 2024 and December 31, 2023, property and equipment, net, which include assets under finance leases, consist of the following (in thousands):


	Asset Lives	March 31, 2024		December 31, 2023
Land		$	46,806	$	47,173
Land improvements	5 to 20 years	20,621		20,487
Buildings and building improvements	10 to 40 years	848,055		845,873
Furniture and equipment	5 to 10 years	59,081		58,443
Automobiles	5 to 7 years	2,696		2,687
Assets under financing leases and leasehold improvements (1)		3,361		2,766
Construction in progress		583		259
Total property and equipment		$	981,203	$	977,688
Less accumulated depreciation and amortization		(399,301)		(389,509)
Total property and equipment, net		$	581,902	$	588,179

__________

(1) Leasehold improvements are amortized over the shorter of the useful life of the asset or the remaining lease term. Assets under financing leases and leasehold improvements include $0.1 million and $0.1 million of financing lease right-of-use assets as of March 31, 2024 and December 31, 2023, respectively.

There were no impairments on long-lived assets for the three months ended March 31, 2024 and 2023.

5. Accrued Expenses

The following is a summary of accrued expenses as of March 31, 2024 and December 31, 2023 (in thousands):


	March 31, 2024		December 31, 2023
Accrued payroll and employee benefits	$	16,721	$	15,639
Accrued interest (1)	9,194		11,316
Accrued taxes	5,489		7,614
Accrued professional fees	5,625		5,022
Accrued other expenses	2,718		2,797
Total accrued expenses	$	39,747	$	42,388

__________

(1) Includes deferred interest of $5.9 million and $4.3 million as of March 31, 2024 and December 31, 2023, respectively, in consideration of the Fannie Mae Loan Modification (as defined below).

6. Notes Payable

Notes payable consists of the following (in thousands):


	Weighted average interest rate	Maturity Date	March 31, 2024		December 31, 2023
Fixed rate mortgage notes payable	4.6%	2025 to 2045	$	418,275	$	492,998
Variable rate mortgage notes payable (1)	6.3%	2026 to 2029	162,114		137,320
Notes payable - insurance	6.3%	2024	854		1,846
Notes payable - other	8.5%	2024	1,213		1,619
Notes payable			$	582,456	$	633,783
Deferred loan costs, net			4,358		4,361
Total notes payable, net of deferred loan costs			$	578,098	$	629,422
Current portion of notes payable			6,831		42,323
Long-term notes payable, net			$	571,267	$	587,099

_____________

(1) See Note 14 for interest rate cap agreements on variable rate mortgage notes payable.

The following schedule summarizes our notes payable as of March 31, 2024 (in thousands):


Principal payments due in:
2024	$	8,075
2025	31,434
2026	335,214
2027	3,597
2028	3,719
Thereafter	200,417
Total notes payable, excluding deferred loan costs	$	582,456

As of March 31, 2024, our fixed rate mortgage notes bear interest rates ranging from 3.6% to 6.3%. Our variable rate mortgage notes are based on the Secured Overnight Financing Rate (“SOFR”) plus an applicable margin. As of March 31, 2024, the one-month SOFR was 5.3% and the applicable margins were either 2.14% or 3.50%.

As of March 31, 2024, we had property and equipment with a net carrying value of $565.5 million that is secured by outstanding notes payable.

Protective Life Insurance Company Loan Repurchase Agreement and Ally Term Loan Expansion

We entered into an agreement with Protective Life Insurance Company (“Protective”) pursuant to which, subject to the terms and conditions set forth therein, the Company agreed to purchase the outstanding indebtedness it owed to Protective for a purchase price of $40.2 million (plus the reimbursement of certain amounts advanced to the Company by Protective). On February 2, 2024, the Company completed the purchase of the total outstanding principal balance of $74.4 million from Protective Life that was secured by seven of the Company’s senior living communities (such transaction, the “Protective Life Loan Purchase”). The Protective Life Loan Purchase was funded by expanding the Company’s existing loan facility with Ally Bank (“Ally”) by $24.8 million and the remainder was funded by proceeds from the 2024 Private Placement, see “Note 7 –Securities Financing.” The Protective Life Loan Purchase and Ally financing closed on February 2, 2024, reduced notes payable by $49.6 million, and resulted in a gain on debt extinguishment totaling $38.1 million. The Company incurred deferred loan costs of $0.5 million as part of the Ally financing that will be amortized over the loan term. As part of the agreement with Ally, the Company expanded its current interest rate cap to include the additional borrowing at a cost of $0.6 million. The expanded Ally debt facility is secured by six of the Company’s senior living communities involved in the Protective Life Loan Purchase.

Fannie Mae Loan Modification

On June 29, 2023, the Company entered into the Fannie Forbearance with Federal National Mortgage Association (“Fannie Mae”) for all 37 of its encumbered communities, effective as of June 1, 2023 (“Fannie Forbearance Effective Date”). Under the Fannie Forbearance, Fannie Mae agreed to forbear on its remedies otherwise available under the community mortgages and Master Credit Facility (“MCF”) in connection with reduced debt service payments made by the Company during the forbearance period. In connection with the Fannie Forbearance, the Company made a $5.0 million principal payment in July 2023. The Fannie Forbearance was the first of a two-step process to modify all existing mortgage loan agreements with Fannie Mae by October 2023 under proposed loan modification agreements, as defined in the Fannie Forbearance (“Loan Modification Agreements”). Terms outlined in an agreed upon term sheet accompanying the Fannie Forbearance were included in the Loan Modification Agreements as the final step to modify the various 37 Fannie Mae community mortgages and MCF prior to the expiration of the Fannie Forbearance, which was subsequently extended to October 6, 2023.

The Company entered into Loan Modification Agreements with Fannie Mae on October 2, 2023. The material terms of the Loan Modification Agreements were as follows:

•Maturities on 18 community mortgages, ranging from July 2024 to December 2026, were extended to December 2026. The remaining 19 communities under the MCF have existing maturities in January 2029.

•The Company is not required to make scheduled principal payments due under the 18 community mortgages and 19 communities under the MCF through the revised maturity date of December 2026 or 36 months from the Fannie Forbearance Effective Date, respectively.

•The monthly interest rate was reduced by a 1.5% weighted average on all 37 communities for 12 months from the Fannie Forbearance Effective Date and deferred (the “Fannie Interest Abatement Period”). On June 1, 2024, the reduced interest rates will expire.

•The Company is required to make a second principal payment of $5.0 million with respect to the Fannie Mae debt which is due on June 1, 2024, the one-year anniversary of the Fannie Forbearance Effective Date.

•The Company provided a full corporate guaranty in the amount of $5.0 million related to the second principal payment of $5.0 million (the “Second Payment Guaranty”). This guaranty will fully expire upon payment of the second $5.0 million principal payment due June 1, 2024.

•In addition to the Second Payment Guaranty above, the Company also provided a $10.0 million guaranty (the “Supplemental Fannie Guaranty”). After the expiration of 24 months from the Fannie Forbearance Effective Date, Sonida may discharge the full amount of the Supplemental Fannie Guaranty by making a $5.0 million principal payment to Fannie Mae on its community mortgages and/or its MCF.

•In the first twelve months following the effective date of the Loan Modification Agreements, the Company is required to escrow 50% of Net Cash Flow less Debt Service (as defined in the Fannie mortgages and MCF) on an aggregate basis over all 37 Fannie Mae communities. The excess cash flow will be deposited into a lender-controlled capital expenditure reserve on a monthly basis to support the re-investment into certain communities, as mutually determined by the Company and Fannie Mae. The Company will be able to draw down such amounts on qualifying projects as the capital expenditures are incurred.

The Company determined that the Fannie loan modification was a troubled debt restructuring where the total cash outflows exceed the current carrying value of the debt. Restructuring costs related to the Loan Modification Agreements are included in deferred loan costs and are being amortized over the lives of the Fannie Mae loans.

Transactions Involving Certain Fannie Mae Loans

During 2020, the Company initiated a process to transfer the operations and ownership of 18 properties to Fannie Mae. In January 2023, the Company received notice that the foreclosure sales conducted by Fannie Mae had successfully transitioned the remaining two properties to new owners. This event relieved the Company of the existing Fannie Mae debt relating to the two properties. Accordingly, the Company recognized a total of $36.3 million for the gain on debt extinguishments for the three months ended March 31, 2023. With the transition of these two remaining properties, the 18 total Fannie Mae properties’ foreclosure was complete.

2024 Ally Loan Amendment

On February 2, 2024, the Company expanded the existing loan facility with Ally by $24.8 million to partially fund the Protective Life Loan Purchase. The Company incurred deferred loan costs of $0.5 million as part of the Ally financing that will be amortized over the loan term. As part of the agreement with Ally, the Company expanded its current interest rate cap to include the additional loan obligation at a cost of $0.6 million. The expanded Ally debt facility is secured by six of the Company’s senior living communities involved in the Protective Life Loan Purchase.

Some terms with Ally on the expanded loan facility include: delayed draws will not be available until successful syndication of the loan, a payroll tax reserve account was established, and certain financial covenant requirements were updated.

2023 Ally Loan Amendment

On June 29, 2023, and concurrent with the Fannie Forbearance, we executed an amendment (“2023 Ally Amendment”) to the Ally term loan agreement (“Ally Term Loan” or “Ally Term Loan Agreement”) and an amended guaranty (“Second Amended Ally Guaranty”) with Ally Bank with terms as follows:

•With respect to the Second Amended Ally Guaranty, Ally will grant the Company, as Guarantor, a waiver (“Limited Payment Guaranty Waiver” or “Waiver”) of the liquid assets minimum requirement of $13.0 million for a 12-month period. On July 1, 2024, a new liquid assets threshold of $7.0 million will be effective, with such threshold increasing $1.0 million per month through the earlier of the release of the Waiver period or December 31, 2024.

•During the Waiver period, a new and temporary liquid assets minimum threshold (“Limited Payment Guaranty Waiver Minimum Threshold”) will be established. The Limited Payment Guaranty Waiver Minimum Threshold is $6.0 million and is measured weekly. If breached, the “Excess Cash Flow Sweep” is triggered and all excess cash from the communities collateralizing the Ally Term Loan will be swept into an “Equity Cure Fund”, as defined in the Ally Term Loan Agreement. As provided for in the 2023 Ally Amendment, the Excess Cash Flow Sweep, if triggered, will cease upon the achievement of meeting or exceeding the Limited Payment Guaranty Waiver Minimum Threshold for four consecutive weeks. Consistent with the Ally Term Loan, all amounts held in escrow (i.e., Debt Service Escrow and IRC Reserve) will be included and combined with the Company’s unrestricted cash for purposes of measurement against the Limited Payment Guaranty Waiver Minimum Threshold.

•During the Waiver period, Ally will collect the equivalent of the monthly Ally Term Loan principal payment (as provided for in the Ally Term Loan Agreement) of approximately $117,000 through an Ally controlled escrow (“Waiver Principal Reserve Account”).

•Upon meeting the Ally Term Loan’s Liquid Assets Threshold of $13.0 million, the Company may elect to remove the Waiver, with initial terms in the Ally Term Loan applicable again, except as described further below.

•In July 2023, we were required to fund $2.3 million to an interest rate cap reserve (“IRC Reserve”) held by Ally, which represented the quoted cost of a one-year interest rate cap on the full $88.1 million notional value of the Ally Term Loan at a 2.25% SOFR strike rate. On December 1, 2023, the Company entered into a new SOFR-based interest rate cap transaction for an aggregate notional amount of $88.1 million at a cost of $2.4 million. The interest rate cap agreement has a 12-month term and caps the floating interest rate portion of our indebtedness with Ally Bank at 2.25%. Until the terms of the Limited Payment Guaranty Waiver have expired or have been met and elected at the Company’s discretion, the IRC Reserve is required to be replenished to its replacement cost.

•To the extent either the Second Payment Guaranty or Supplemental Fannie Guaranty have not been discharged, any uncured monetary event of default under the Fannie Forbearance will constitute a cross default under the 2023 Ally Amendment, resulting in the immediate trigger of a full excess cash flow sweep for the communities collateralizing the Ally Term Loan as well as additional performance and liquidity reporting requirements.

•Subsequent to the Waiver period, all funds in the Waiver Principal Reserve Account as well as any funds swept into the Equity Cure Fund will be released to the Company.

The foregoing description of the Fannie Forbearance, the 2023 Ally Amendment, Second Amended Ally Guaranty, and the Loan Modification Agreements and the transactions contemplated thereby do not purport to be complete and are subject to, and qualified in their entirety by, the full text of the Fannie Forbearance, the 2023 Ally Amendment and Second Amended Ally Guaranty which are filed as Exhibits 10.21, 10.22 and 10.23, respectively, and the Loan Modification Agreements, which are filed as Exhibits 10.24 and 10.25 to the Company’s Annual Report on Form 10-K filed with the SEC on March 27, 2024.

Notes Payable - Insurance

During the year ended December 31, 2023, the Company renewed certain insurance policies and entered into several finance agreements totaling approximately $3.3 million. As of March 31, 2024, the Company had finance agreements totaling $0.9 million, with fixed interest rates ranging from 6.25% to 6.50%, and weighted average rate of 6.32%, with principal amounts being fully repaid over ten-month terms.

Other Debt Transactions

The Company had notes payable related to rent payments due to Healthpeak as of March 31, 2024 and December 31, 2023 of $1.2 million and $1.6 million, respectively. In November 2023, the Company modified its payment terms on the Healthpeak note payable to include four consecutive quarterly installments beginning in January 2024.

Debt Covenant Compliance

The Company was in compliance with its debt covenants related to its outstanding indebtedness as of March 31, 2024.

7. Securities Financing

Increase in Authorized Shares of Common Stock

On March 21, 2024, following receipt of stockholder approval at the Special Meeting of the Company’s stockholders held on March 21, 2024, the Company filed an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, with the Delaware Secretary of State to increase the number of authorized shares of the Company’s common stock from 15,000,000 shares to 30,000,000 shares (the “Stockholder Approval”). The charter amendment became effective upon filing.

2024 Private Placement Transaction

On February 1, 2024, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with Conversant Dallas Parkway (A) LP, Conversant Dallas Parkway (B) LP and several other shareholders (together, the “Investors”), pursuant to which the Investors agreed to purchase from the Company, and the Company agreed to sell to the Investors, in a private placement transaction (the “2024 Private Placement”) pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), an aggregate of 5,026,318 shares of the Company’s common stock at a price of $9.50 per share.

The 2024 Private Placement occurred in two tranches. The first tranche occurred on February 1, 2024, at which time 3,350,878 shares of common stock were issued and sold to the Investors for $31.8 million. The second tranche occurred on March 22, 2024, at which time 1,675,440 shares of common stock were issued and sold to the Investors for $15.9 million. The Company used a portion of the proceeds from the first closing of the 2024 Private Placement to fund a portion of the cash purchase price for the Protective Life Loan Purchase and the Company intends to use the remaining proceeds for ongoing working capital, continued investments in community improvements, potential acquisitions of new communities, broader community programming and general corporate purposes. As of March 22, 2024, the majority of our common stock is held by Conversant Dallas Parkway (A) LP, Conversant Dallas Parkway (B) LP, and Conversant Dallas Parkway (D) LP (together, “Conversant” or the “Conversant Investors”).

Series A Preferred Stock

In November 2021, the Company issued 41,250 shares of Series A Preferred Stock. The Series A Preferred Stock is convertible outside of the Company's control and, in accordance with GAAP, is classified as mezzanine equity, outside the stockholders’ equity (deficit) section, on our condensed consolidated balance sheets.

The Series A Preferred Stock has an 11% annual dividend calculated on the original investment of approximately $41.3 million accrued quarterly in arrears and compounded. Dividends are cumulative, and any declaration of dividends is at the discretion of the Company’s Board of Directors. If the Board does not declare a dividend in respect of any dividend payment date, the amount of such accrued and unpaid dividend is added to the liquidation preference and compounds quarterly thereafter. On March 31, 2024, the Board did not declare dividends with respect to the Series A Preferred Stock, and accordingly, $1.3 million was added to the liquidation preference of the Series A Preferred Stock, effectively increasing the carrying value of the Series A Preferred Stock. As of March 31, 2024, a total of $8.6 million has been added to the liquidation preference of the Series A Preferred Stock.

Conversant Equity Commitment

In connection with the Fannie Forbearance and 2023 Ally Amendment signed on June 29, 2023, the Company entered into a $13.5 million equity commitment agreement (“Equity Commitment”) with Conversant for a term of 18 months. Sonida has the right, but not the obligation, to utilize Conversant’s equity commitment and may draw on the commitment in whole or in part, subject to the terms and conditions therein and applicable laws and regulations. As of March 31, 2024, the Company had $3.5 million remaining under its Equity Commitment with Conversant, and the Equity Commitment is in effect through December 31, 2024.

At-the-Market Equity Offerings

See “Note 15 –Subsequent Even t s” for the Company’s At-the-Market Issuance Sales Agreement entered into on April 1, 2024 and subsequent equity issuances.

8. Revenue

Revenue for the three months ended March 31, 2024 and 2023 is comprised of the following components (in thousands):


	Three Months Ended March 31,
		2024		2023
Housing and support services		$	59,984	$	53,791
Community fees		459		479
Ancillary services		294		273
Other operating revenue (1)		—		2,063
Resident revenue		60,737		56,606
Management fees		594		505
Managed community reimbursement revenue		6,107		4,962
Total revenues		$	67,438	$	62,073

__________

(1) Other operating revenue consists of funds received from state departments due to financial distress impacts of COVID-19. The Company intends to pursue any additional funding that may become available in the future, but there is no guarantee any additional funds will be available or that the Company will qualify for, or receive, any additional relief funds that become available.

Community fees, ancillary services, management fees, and community reimbursement revenue represent revenue from contracts with customers in accordance with GAAP.

9. Net Income Per Share

Basic net income per share (“EPS”) is calculated by dividing net earnings by the weighted average number of common shares outstanding during the period. Potentially dilutive securities include warrants, Series A Preferred Stock, shares of restricted stock, restricted stock units, and former employee stock options. Diluted EPS reflects the assumed exercise or conversion of all

dilutive securities. The Series A Preferred Stock is considered participating securities for the purposes of the Company's EPS calculation.

The following table sets forth the computation of basic and diluted net income per share (in thousands, except for per share amounts):


	Three Months Ended March 31,
		2024		2023
Basic net income per common share calculation:
Net income		$	27,019	$	24,145

Less: Undeclared dividends on Series A Preferred Stock		(1,335)		(1,198)
Less: Undistributed earnings allocated to participating securities		(2,849)		(3,182)
Net income attributable to common stockholders		$	22,835	$	19,765
Weighted average shares outstanding — basic		9,861		6,855
Basic net income per share		$	2.32	$	2.88

Diluted net income per common share calculation:
Net income attributable to common stockholders		$	22,835	$	19,765
Weighted average shares outstanding — diluted		10,562		7,168
Diluted net income per share		$	2.16	$	2.76

The following weighted-average shares of securities were not included in the computation of diluted net income per common share as their effect would have been antidilutive:


	Three Months Ended March 31,
(shares in thousands)		2024	2023
Warrants		1,031	1,031
Series A Preferred Stock (if converted)		1,230	1,104
Restricted stock awards		22	190

Stock options		10	10
Total		2,293	2,335

10. Stock-Based Compensation

The Company’s uses equity awards as a long-term retention program that is intended to attract, retain and provide incentives for employees, officers, and directors and to more closely align stockholder and employee interests. The Company recognizes compensation expense for all of its share-based stock awards based on their fair values.

The Company recognized $0.6 million and $0.9 million in stock-based compensation expense for the three months ended March 31, 2024 and March 31, 2023, respectively.

11. Commitments and Contingencies

As of March 31, 2024, the Company had contractual commitments of $3.1 million related to future renovations and technology enhancements to its communities, which are expected to be substantially expended during 2024.

The Company has claims incurred in the normal course of its business. Most of these claims are believed by management to be covered by insurance, subject to deductibles, normal reservations of rights by the insurance companies and possibly subject to certain exclusions in the applicable insurance policies. Whether or not covered by insurance, these claims, in the opinion of management, based on advice of legal counsel, should not have a material impact on the condensed consolidated financial statements of the Company.

12. Related Party Transactions

As of March 31, 2024, Conversant and its affiliates beneficially owned approximately 61% of our outstanding shares of common stock (inclusive of common stock issuable upon conversion of outstanding Series A Preferred Stock and outstanding warrants).

During the three months ended March 31, 2024, the Conversant Investors purchased an additional 3,157,895 shares of common stock of the Company for $30.0 million. See “Note 7–Securities Financing.”

13. Fair Value Measurements

Assets and Liabilities Measured at Fair Value on a Recurring Basis

The Company uses interest rate cap arrangements with financial institutions to manage exposure to interest rate changes for loans that utilize floating interest rates. As of March 31, 2024 and December 31, 2023, we had interest rate cap agreements with an aggregate notional value of $113.0 million and $138.4 million, respectively. The fair value of these derivative assets as of March 31, 2024 and December 31, 2023 was $2.1 million and $2.1 million, respectively, which was determined using significant observable inputs (Level 2), including quantitative models that utilize multiple market inputs to value the position. The majority of market inputs are actively quoted and can be validated through external sources, including brokers, market transactions, and third-party pricing services.

Financial Instruments Not Reported at Fair Value

For those financial instruments not carried at fair value, the carrying amount and estimated fair values of our financial assets and liabilities were as follows as of March 31, 2024 and December 31, 2023 (in thousands):


	March 31, 2024				December 31, 2023
	Carrying Amount		Fair Value		Carrying Amount		Fair Value


Cash and cash equivalents	$	24,211	$	24,211	$	4,082	$	4,082
Restricted cash	13,452		13,452		13,668		13,668
Notes payable, excluding deferred loan costs	$	582,456	$	538,271	$	633,783	$	597,266

We believe the carrying amount of cash and cash equivalents, restricted cash, accounts receivable, and accounts payable, and accrued expenses approximate fair value due to their short-term nature.

The fair value of notes payable, excluding deferred loan costs, is estimated using discounted cash flow analysis, based on current incremental borrowing rates for similar types of borrowing arrangements, which represent Level 2 inputs as defined in ASC 820, Fair Value Measurement.

Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis

The Company adjusts the carrying amount of certain non-financial assets to fair value on a non-recurring basis when they are impaired. There were no impairment losses for the three months ended March 31, 2024 and 2023.

14. Derivatives and Hedging

The Company uses derivatives as part of its overall strategy to manage our exposure to market risks associated with the fluctuations in interest rates. We are also required to enter into interest rate derivative instruments in compliance with certain debt agreements. We do not enter into derivative financial instruments for trading or speculative purposes.

On March 1, 2022, the Company entered into an interest rate cap transaction for an aggregate notional amount of $50.3 million to reduce exposure to interest rate fluctuations associated with a portion of its variable mortgage notes payable. The interest rate cap agreement had a 24-month term and effectively capped LIBOR at 4.00% from March 1, 2022 through March 1, 2024 with respect to such floating rate indebtedness. LIBOR rates were no longer available after June 30, 2023, and, as a result, this derivative instrument has transitioned to the SOFR rate. In the event SOFR is less than the capped rate, we will pay interest at the lower SOFR rate. In the event SOFR is higher than the capped rate, we will pay interest at the capped rate of 4.00% plus the

applicable margin. The interest rate cap is not designated as a cash flow hedge under ASC 815-20, Derivatives – Hedging, and therefore, all changes in the fair value of the instrument are included as a component of interest expense in our condensed consolidated statements of operations. See “Note 15 –Su bsequent Events” regarding the Company’s replacement derivative instrument purchased during April 2024.

On December 1, 2023, in order to comply with the lender’s requirements under the Ally Bank loan agreements, the Company entered into a SOFR-based interest rate cap transaction for an aggregate notional amount of $88.1 million at a cost of $2.4 million. The interest rate cap agreement has a 12-month term and effectively caps the interest rate at 2.25% with respect to the portion of our floating rate indebtedness. On February 2, 2024, as part of the Ally Term Loan expansion, the Company entered into a SOFR-based interest rate cap transaction for an aggregate notional amount of $24.8 million at a cost of $0.6 million. See “Note 6 –Notes Payab le.” The interest rate caps are not designated as hedges under ASC 815-20, “Derivatives – Hedging,” and therefore, all changes in the fair value of the instrument are included as a component of interest expense in our condensed consolidated statements of operations.

The following table presents the fair values of derivative assets and liabilities in the condensed consolidated balance sheets (in thousands):


	March 31, 2024
	Derivative Asset				Derivative Liability
	Notional Amount		Fair Value		Notional Amount		Fair Value

Interest rate cap (SOFR-based)	$	112,955	$	2,130	$	—	$	—
Total derivatives, net	$	112,955	$	2,130	$	—	$	—


	December 31, 2023
	Derivative Asset				Derivative Liability
	Notional Amount		Fair Value		Notional Amount		Fair Value

Interest rate cap (SOFR-based)	$	138,385	$	2,103	$	—	$	—
Total derivatives, net	$	138,385	$	2,103	$	—	$	—

The following table presents the effect of the derivative instruments on the condensed consolidated statements of operations (in thousands):



	Three months ended March 31,
		2024		2023
Derivative not designated as hedge
Interest rate cap
Loss on derivatives not designated as hedges included in interest expense		$	(527)	$	(572)

15. Subsequent Events

At-the Market Equity Offerings

On April 1, 2024, the Company entered into an At-the-Market Issuance Sales Agreement (the “ATM Sales Agreement”) with Mizuho Securities USA LLC, who is acting as the sole sales agent (the “Agent”). Pursuant to the ATM Sales Agreement, the Company may sell, at its option, shares of its common stock up to an aggregate offering price of $75,000,000 (the “Shares”) through the Agent. Sales of the Shares made pursuant to the ATM Sales Agreement, if any, will be made under the Company’s Registration Statement on Form S-3 filed with the SEC on May 1, 2023 (File No. 333-271545), which includes a base prospectus and was declared effective on May 9, 2023 (the “Registration Statement”), and the prospectus supplement dated April 1, 2024 relating to the offering and filed with the SEC on April 1, 2024 (the “Prospectus Supplement”), in each case, as may be amended or supplemented from time to time.

Subject to the terms and conditions of the ATM Sales Agreement, the Company may propose that the Agent place Shares pursuant to the terms set forth in a placement notice (each, a “Transaction”). The Agent may sell the Shares, if any, in a Transaction only by methods deemed to be an “at the market offering” as defined in Rule 415 promulgated under the Securities Act, including without limitation sales made directly on The New York Stock Exchange, on any other trading market for the

common stock or to or through a market maker. In addition, the Agent may, with the Company’s prior written consent, sell Shares by any other method permitted by law, including negotiated transactions. The Agent will use commercially reasonable efforts consistent with its normal trading and sales practices to sell the Shares in a Transaction in accordance with the terms of the ATM Sales Agreement and any applicable placement notice.

The ATM Sales Agreement provides that the Agent will be entitled to receive a commission of up to 3% of the gross proceeds from the sale of the Shares in a Transaction. Pursuant to the terms of the ATM Sales Agreement, the Company also provided the Agent with customary indemnification and contribution rights. The offering of common stock pursuant to the ATM Sales Agreement will terminate upon the earlier of, among other things, (i) the sale of all of the Shares subject to the ATM Sales Agreement and (ii) the termination of the ATM Sales Agreement by the Company or by the Agent, following delivery of sufficient written notice by the Company or the Agent to the other party. The Company cannot provide any assurances that it will issue any additional Shares pursuant to the ATM Sales Agreement.

The Company currently anticipates that the net proceeds from the sale of the Shares offered pursuant to the ATM Sales Agreement, if any, will be used for potential acquisition opportunities, capital expenditure projects at the Company’s senior living communities, working capital and other general corporate purposes. See “Item 6. Exhibits.”

On April 5, 2024, the Company sold 382,000 shares pursuant to the ATM Sales Agreement at $27.50 per share for net proceeds of $10.3 million, inclusive of $0.2 million in commissions paid to its Agent. The Company cannot provide any assurances that it will issue any additional shares of common stock pursuant to the ATM Sales Agreement.

Derivative Purchase

During April 2024, the Company entered into an interest rate cap transaction for an aggregate notional amount of $49.2 million for $1.1 million to reduce exposure to interest rate fluctuations associated with a portion of our variable mortgage notes payable to Fannie Mae. The interest rate cap has 24-month term and effectively caps SOFR at 4.00% from April 1, 2024 through April 1, 2026 with respect to such floating rate indebtedness. In the event SOFR is less than the capped rate, we will pay interest at the lower SOFR rate. In the event SOFR is higher than the capped rate, we will pay interest at the capped rate of 4.00% plus the applicable margin. The Company is funding an IRC reserve for a replacement IRC which is held by the lender.

Macedonia Acquisition

In April 2024, the Company entered into an asset purchase agreement to acquire a community located in Macedonia, Ohio and all in-place leases for a purchase price totaling $10.7 million that closed on May 9, 2024. In conjunction with the closing, the Company entered into a mortgage loan totaling $9.4 million. The Company also entered into a SOFR-based interest rate cap to reduce exposure to the variable interest rate fluctuations associated with the new mortgage. The total cost of the IRC was $0.2 million and has an aggregate notional amount of $9.4 million. The IRC has a 24-month term and effectively caps SOFR at 6.00% from May 9, 2024 through May 1, 2026 with respect to such floating rate indebtedness.

Management Agreement Letter of Intent

During March 2024, the Company received a Non-Binding Letter of Intent from a public Real Estate Investment Trust in which the Company would manage three properties in exchange for a management fee. The transition of the three properties is anticipated to occur on June 1, 2024. The completion of this potential transaction is subject to several conditions, including the completion of satisfactory due diligence and the negotiation and execution of definitive management agreements. Accordingly, there can be no assurance that this potential transaction will be completed upon the terms or dates contemplated, if at all.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to help provide an understanding of our business and results of operations. This MD&A should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes thereto included elsewhere in this Quarterly Report on Form 10-Q. This report, including the following MD&A, contains forward-looking statements regarding future events or trends that should be read in conjunction with the risks, uncertainties and other factors described under “Cautionary Note Regarding Forward-Looking Statements” above in this Quarterly Report on Form 10-Q and “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on March 27, 2024, as well as “Item. 1A. Risk Factors” in this Quarterly Report on Form 10-Q. Actual results may differ materially from those projected in such statements as a result of such risks, uncertainties and other factors. Unless otherwise specified or where the context otherwise requires, references in this Report to “our,” “we,” “us,” “Sonida”, the “Company” and “our business” refer to Sonida Senior Living, Inc., together with its consolidated subsidiaries.

Overview

The following discussion and analysis addresses (i) the Company’s results of operations for the three months ended March 31, 2024 and 2023, and (ii) liquidity and capital resources of the Company.

The Company is one of the leading owner-operators of senior housing communities in the United States. The Company’s operating strategy is to provide value to its senior living residents by providing quality senior living services at reasonable prices, while achieving and sustaining a strong, competitive position within its geographically concentrated regions, as well as continuing to enhance the performance of its operations. The Company generally provides senior living services to the 75+ population, including independent living, assisted living, and memory care services at reasonable prices. Many of the Company’s communities offer a continuum of care to meet each of their resident’s needs as they change over time. This continuum of care, which integrates independent living, assisted living, and memory care that may be bridged by home care through independent home care agencies, sustains our residents’ autonomy and independence based on their physical and mental abilities.

As of March 31, 2024, the Company operated 71 senior housing communities in 18 states with an aggregate capacity of approximately 8,000 residents, including 61 owned senior housing communities and 10 communities that the Company third-party manages.

Significant Financial and Operational Highlights

Operations

The Company derives its revenue primarily by providing senior living and healthcare services to seniors. During the three months ended March 31, 2024, the Company generated resident revenue of approximately $60.7 million compared to approximately $56.6 million during the three months ended March 31, 2023, representing an increase of 7.3%. The increase in revenue was primarily due to increased occupancy and increased average rent rates.

Weighted average occupancy for the three months ended March 31, 2024 and 2023 for the communities owned by the Company was 85.9% and 83.9%, respectively, reflecting continued occupancy recovery. The average monthly rental rate for the three months ended March 31, 2024 was 5.9% higher as compared to the three months ended March 31, 2023.

Management Services

The Company has property management agreements with affiliates of Ventas, Inc. (collectively, “Ventas”) pursuant to which the Company manages certain communities for Ventas, and Ventas pays the Company a management fee based on gross revenues of the applicable communities, as well as an incentive management fee, and other customary terms and conditions. The Company managed ten communities on behalf of Ventas during the three months ended March 31, 2024 and 2023.

Protective Life Insurance Company Loan Repurchase Agreement and Ally Term Loan Expansion

(“Ally”) by $24.8 million and the remainder was funded by proceeds from the 2024 Private Placement described below. The Protective Life Loan Purchase and Ally financing closed on February 2, 2024, reduced notes payable by $49.6 million, and resulted in a gain on debt extinguishment totaling $38.1 million. The Company incurred deferred loan costs of $0.5 million as part of the Ally financing that will be amortized over the loan term. As part of the agreement with Ally, the Company expanded its current interest rate cap to include the additional borrowing at a cost of $0.6 million. The expanded Ally debt facility is secured by six of the Company’s senior living communities involved in the Protective Life Loan Purchase.

Increase in Authorized Shares of Common Stock

2024 Private Placement Transaction

The 2024 Private Placement occurred in two tranches. The first tranche occurred on February 1, 2024, at which time 3,350,878 shares of common stock were issued and sold to the Investors for a total of approximately $31.8 million. The second tranche occurred on March 22, 2024, at which time 1,675,440 shares of common stock were issued and sold to the Investors for a total of approximately $15.9 million. The second tranche occurred following receipt of the Stockholder Approval. The Company used a portion of the proceeds from the first closing of the 2024 Private Placement to fund a portion of the cash purchase price for the Protective Life Loan Purchase. The Company intends to use the remaining proceeds for ongoing working capital, continued investments in community improvements, potential acquisitions of new communities, broader community programming and general corporate purposes. As of March 22, 2024, the majority of our common stock is held by Conversant Dallas Parkway (A) LP, Conversant Dallas Parkway (B) LP, and Conversant Dallas Parkway (D) LP (together, “Conversant” or the “Conversant Investors”).

Other Significant Transactions

Fannie Mae Loan Modification

The Company entered into Loan Modification Agreements with Fannie Mae on October 2, 2023. The material terms of the Loan Modification Agreements were as follows:

•Maturities on 18 community mortgages, ranging from July 2024 to December 2026, were extended to December 2026. The remaining 19 communities under the MCF have existing maturities in January 2029.

Transactions Involving Certain Fannie Mae Loans

2024 Ally Loan Amendment

2023 Ally Loan Amendment

$6.0 million and is measured weekly. If breached, the “Excess Cash Flow Sweep” is triggered and all excess cash from the communities collateralizing the Ally Term Loan will be swept into an “Equity Cure Fund”, as defined in the Ally Term Loan Agreement. As provided for in the 2023 Ally Amendment, the Excess Cash Flow Sweep, if triggered, will cease upon the achievement of meeting or exceeding the Limited Payment Guaranty Waiver Minimum Threshold for four consecutive weeks. Consistent with the Ally Term Loan, all amounts held in escrow (i.e., Debt Service Escrow and IRC Reserve) will be included and combined with the Company’s unrestricted cash for purposes of measurement against the Limited Payment Guaranty Waiver Minimum Threshold.

•Subsequent to the Waiver period, all funds in the Waiver Principal Reserve Account as well as any funds swept into the Equity Cure Fund will be released to the Company.

Conversant Equity Commitment

Application of Critical Accounting Policies and Estimates

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. For a discussion of our critical accounting policies and estimates, please refer to our Annual Report on Form 10-K for the year ended December 31, 2023. There have been no significant changes to our critical accounting policies since December 31, 2023.

Recent Accounting Guidance Adopted

See “Note 3–Summary of Significant Accounting Policies” in the Notes to Condensed Consolidated Financial Statements for a discussion of new accounting pronouncements and our assessment of any expected impact of these pronouncements, if known.

Results of Operations

Three months ended March 31, 2024 as compared to three months ended March 31, 2023

Revenues

Resident revenue for the three months ended March 31, 2024 was $60.7 million as compared to $56.6 million for the three months ended March 31, 2023, an increase of $4.1 million, or 7.3%. The increase in revenue was primarily due to increased occupancy and increased average rent rates. For the three months ended March 31, 2023, the Company received approximately $2.0 million in various relief funds received from state departments due to financial distress impacts of COVID-19 (“State Relief Funds”). For the three months ended March 31, 2024, the Company received no State Relief Funds.

Expenses

Operating expenses for the three months ended March 31, 2024 were $46.3 million as compared to $43.8 million for the three months ended March 31, 2023, representing an increase of $2.5 million, or 5.7%. In our consolidated community portfolio, the labor component of our operating expense increased approximately $2.5 million period-over-period.

General and administrative expenses for the three months ended March 31, 2024 were $7.2 million as compared to $7.1 million for the three months ended March 31, 2023, representing an increase of $0.1 million. The increase was primarily a result of an increase in labor and employee related expenses of $0.6 million, partially offset by decreases in stock-based compensation of $0.3 million and other expenses of $0.2 million.

Interest expense for the three months ended March 31, 2024 was $8.6 million as compared to $8.9 million for the three months ended March 31, 2023, representing a decrease of $0.3 million primarily due to reduced debt balances during 2024.

Gain on extinguishment of debt for the three months ended March 31, 2024 was $38.1 million. The gain relates to the derecognition of notes payable and liabilities as a result of the Protective Life Loan Purchase. Gain on extinguishment of debt for the three months ended March 31, 2023 was $36.3 million and related to the derecognition of notes payable and liabilities as a result of the transition of legal ownership of two communities to Fannie Mae, the holder of the related non-recourse debt.

Other expense for the three months ended March 31, 2024 was $0.5 million as compared to other income of $0.2 million for the three months ended March 31, 2023. For the three months ended March 31, 2024, other expense is primarily related to transaction costs incurred as a result of the Ally Term Loan expansion and the Protective Life Loan Purchase.

Liquidity and Capital Resources

In addition to $24.2 million of unrestricted cash balances on hand as of March 31, 2024, our future liquidity will depend in part upon our operating performance, which will be affected by prevailing economic conditions, and financial, business and other factors, some of which are beyond our control. Principal sources of liquidity are expected to be cash flows from operations, proceeds from equity offerings, proceeds from debt refinancings or loan modifications, and proceeds from the sale of owned assets. During 2023, we entered into loan modifications with Fannie Mae, an amendment with Ally Bank, including a revised Limited Payment Guaranty, and an Equity Commitment with Conversant. During the first quarter of 2024, we completed the 2024 Private Placement pursuant to which we issued and sold an aggregate of 5,026,318 shares of our common stock to several of our shareholders for gross cash proceeds of approximately $47.8 million, which enabled us to purchase all of the Company’s debt then outstanding with Protective Life at a substantial discount, as well as fund future working capital and growth initiatives. Additional financing of $24.8 million for the debt purchase was provided by Ally Bank through an expansion of the Company’s existing Ally Bank term loan. On April 1, 2024, the Company entered into the At-the-Market Issuance Sales Agreement (the “ATM Sales Agreement”) with Mizuho Securities USA LLC, whereby the Company may sell, at its option, shares of its common stock up to an aggregate offering price of $75,000,000. These transactions are expected to provide additional financial flexibility to us and increase our liquidity position. See “Note 6–Notes Payable,” “Note 7 –Securit ies Fi nancing,” and “Note 15 –Subse quent Ev ents” in the Notes to Condensed Consolidated Financial Statements.

In February 2024, in order to comply with Ally term loan requirements, the Company expanded its SOFR-based interest rate cap for an aggregate notional amount of $24.8 million at a cost of $0.6 million. The interest rate cap agreement has a 12-month term and caps the floating interest rate portion of our indebtedness with Ally Bank at 2.25%. As of December 31, 2023, the entire balance of our outstanding variable-rate debt obligations were covered by our interest rate caps to better manage our exposure to market risks associated with the fluctuations in interest rates.

During 2023, the Company's liquidity conditions, including operating losses and net working capital deficit, raised substantial doubt about the Company's ability to continue as a going concern. As a result of increases in occupancy, increases in rental rates and completion of the 2024 Private Placement and Protective Life Loan Purchase, the Company has substantially

improved its liquidity position. In addition, net proceeds of $10.3 million was raised in April 2024 through our ATM Sales Agreement. These transactions have increased cash on hand significantly. Based on these events, the Company concluded it has adequate cash to meet its obligations as they become due for the 12-month period following the date the March 31, 2024 financial statements are issued.

The Company, from time to time, considers and evaluates financial and capital raising transactions related to its portfolio, including debt refinancings, purchases and sales of assets, equity offerings and other transactions. There can be no assurance that the Company will continue to generate cash flows at or above current levels, or that the Company will be able to obtain the capital necessary to meet the Company’s short- and long-term capital requirements.

Recent changes in the current economic environment, and other future changes, could result in decreases in the fair value of assets, slowing of transactions, and the tightening of liquidity and credit markets. These impacts could make securing debt or refinancings for the Company or buyers of the Company’s properties more difficult or on terms not acceptable to the Company. The Company’s actual liquidity and capital funding requirements depend on numerous factors, including its operating results, its capital expenditures for community investment, and general economic conditions, as well as other factors described in “Item 1A. Risk Factors” of our 2023 Annual Report on Form 10-K filed with the SEC on March 27, 2024.

In summary, the Company’s cash flows were as follows (in thousands):


	Three months ended March 31,
	2024		2023		$ Change
Net cash provided by (used in) operating activities	$	(4,105)	$	3,249	$	(7,354)
Net cash used in investing activities	(5,131)		(5,086)		(45)
Net cash provided by (used in) financing activities	29,149		(3,759)		32,908
Increase (decrease) in cash and cash equivalents and restricted cash	$	19,913	$	(5,596)	$	25,509

Operating activities

Net cash used in operating activities for the three months ended March 31, 2024 was $4.1 million as compared to net cash provided by operating activities of $3.2 million for the three months ended March 31, 2023. The change of $7.4 million is primarily due to the settlement of accounts payable and accrued expenses from the proceeds of the 2024 Private Placement, and to a lesser extent, timing of accounts receivable collections during the three months ended March 31, 2024.

Investing activities

Net cash used in investing activities was $5.1 million in the three months ended March 31, 2024 primarily results from ongoing capital improvements and refurbishments at the Company’s senior housing communities of $5.7 million, offset by $0.6 million from the proceeds from the sale of an unencumbered land parcel in January 2024. Net cash used in investing activities of $5.1 million for the three months ended March 31, 2023 is primarily the result of ongoing capital improvements and refurbishments at the Company’s senior housing communities of $5.4 million, partially offset by $0.3 million from the proceeds from the sale of an unencumbered land parcel in March 2023.

Financing activities

Net cash provided by financing activities for the three months ended March 31, 2024 was $29.1 million primarily due to net proceeds from the issuance of common stock of $47.6 million and proceeds of $24.8 million from notes payable, partially offset by repayments of notes payable of $42.0 million. The net cash used in financing activities for the three months ended March 31, 2023 was $3.8 million primarily due to repayments of notes payable.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not applicable.

Item 4. Controls and Procedures

Effectiveness of Controls and Procedures

The Company’s management, with the participation of the Company’s Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. The Company’s disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. The Company’s disclosure controls and procedures are also designed to ensure that such information is accumulated and communicated to the Company’s management, including the CEO and CFO as appropriate, to allow timely decisions regarding required disclosure.

Based upon the controls evaluation, procedures evaluation and the material weakness described in our Annual Report on Form 10-K, which was filed with the SEC on March 27, 2024, the Company’s CEO and CFO have concluded that, as of the end of the period covered by this Quarterly Report on Form 10-Q, the Company’s disclosure controls and procedures are ineffective.

There have not been any changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the Company’s fiscal quarter ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Remediation Plan

As disclosed in our 2023 Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the SEC on March 27, 2024, we identified a material weakness in our internal control over financial reporting, which has not been remediated as of March 31, 2024, as disclosed above.

We have developed and initiated a plan for remediation of the material weakness, including developing and maintaining appropriate management review and process level controls. We will continue to monitor the effectiveness of our remediation measures in connection with our future assessments of the effectiveness of internal control over financial reporting and disclosure controls and procedures, and we will make any changes to the design of our plan and take such other actions that we deem appropriate given the circumstances. Based on the current remediation plan, we expect to have implemented the remediation process, including developing and maintaining appropriate management review and process level controls, by the end of the fourth quarter of 2024. Control weaknesses are not considered remediated until new internal controls have been operational for a period of time, are tested, and management concludes that these controls are operating effectively.

Part II. OTHER INFORMATION

Item 1. Legal Proceedings

The Company has claims incurred in the normal course of its business. Most of these claims are believed by management to be covered by insurance, subject to normal reservations of rights by the insurance companies and possibly subject to certain exclusions in the applicable insurance policies. Whether or not covered by insurance, these claims, in the opinion of management, based on advice of legal counsel, should not have a material effect on the condensed consolidated financial statements of the Company if determined adversely to the Company.

Item 1A. Risk Factors.

There have been no material changes to the risk factors set forth in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2023.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following information is provided pursuant to Item 703 of Regulation S-K. The information set forth in the table below reflects the common stock purchased by the Company for the quarter ended March 31, 2024:

Period

Total

Number

of Shares

Purchased (1)

Average
Price Paid
per Share

Total Shares
Purchased
as Part of
Publicly
Announced
Program

Approximate
Dollar Value of
Shares that May
Yet Be
Purchased
Under the
Program

January 1 – January 31, 2024

6,570,222

February 1 – February 29, 2024

6,570,222

March 1 – March 31, 2024

6,570,222

__________

(1) Does not include shares withheld to satisfy tax liabilities due upon the vesting of restricted stock, all of which have been reported in Form 4 filings relating to the Company. The average price paid per share for such share withholding is based on the closing price per share on the vesting date of the restricted stock or, if such date is not a trading day, the trading day immediately prior to such vesting date.

On January 22, 2009, the Company’s Board approved a share repurchase program that authorized the Company to purchase up to $10.0 million of the Company’s common stock. On January 14, 2016, the Company announced that its Board approved a continuation of the share repurchase program. The repurchase program does not obligate the Company to acquire any particular amount of common stock and the share repurchase authorization has no stated expiration date. All shares that have been acquired by the Company under this program were purchased in open-market transactions. The Company may evaluate whether to acquire additional shares of common stock under this program at its discretion and subject to applicable laws and regulations.

Item 3. Defaults upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Not applicable.

Item 6. Exhibits

The following documents are filed as a part of this report. Those exhibits previously filed and incorporated herein by reference are identified below. Exhibits not required for this report have been omitted.


Exhibit Number						Description

3.1						Amended and Restated Certificate of Incorporation of the Registrant. (Incorporated by reference to Exhibit 3.1 to the Registration Statement No. 333-33379 on Form S-1/A filed by the Company with the Securities and Exchange Commission on September 8, 1997.)

3.1.1						Amendment to Amended and Restated Certificate of Incorporation of the Registrant. (Incorporated by reference to Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 1999, filed by the Company with the Securities and Exchange Commission.)

3.1.2						Second Amendment to Amended and Restated Certificate of Incorporation of the Registrant (Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission on December 14, 2020.)

3.1.3						Third Amendment to Amended and Restated Certificate of Incorporation of the Registrant (Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission on November 4, 2021.)

3.1.4						Fourth Amendment to Amended and Restated Certificate of Incorporation of the Registrant (Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission on November 10, 2021.)

3.1.5						Fifth Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as amended, of Sonida Senior Living, Inc. (Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission on June 16, 2023.)

3.1.6						Sixth Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as amended, of Sonida Senior Living, Inc. (Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission on March 22, 2024.)

3.2						Second Amended and Restated Bylaws of the Registrant. (Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission on March 8, 2013.)

3.2.1						Amendment to the Second Amended and Restated Bylaws of the Registrant (Incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission on November 10, 2021.)

3.2.2						Second Amendment to the Second Amended and Restated Bylaws of Registrant. (Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission on March 27, 2024.)

3.3						Certificate of Designation, Rights and Privileges of Series A Convertible Preferred Stock, par value $0.01, of the Company (Incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission on November 4, 2021.)

10.1						At-The-Market Issuance Sales Agreement, dated April 1, 2024, by and between Sonida Senior Living, Inc. and Mizuho Securities USA LLC. (Incorporated by reference to Exhibit 1.1 to the Company’s Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission on April 1, 2024.)

10.2						Securities Purchase Agreement, dated as of February 1, 2024, by and between Sonida Senior Living, Inc., Conversant Dallas Parkway (A) LP, Conversant Dallas Parkway (B) LP, Silk Partners, LP, PF Investors, LLC, Solas Capital Partners, LP, Solas Capital Partners II, LP, Blackwell Partners LLC - Series A, and Paul J. Isaac. (Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission on February 6, 2024.)

31.1*						Certification of Principal Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a)

31.2*						Certification of Principal Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a)

32.1*						Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2*						Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101*						The following materials from the Company’s Quarterly Report on Form 10-Q for the three months ended March 31, 2024 formatted in Inline Extensible Business Reporting Language (iXBRL): (i) the Condensed Consolidated Statements of Operations, (ii) the Condensed Consolidated Balance Sheets, (iii) the Condensed Consolidated Statements of Cash Flows, (iv) the Condensed Consolidated Statements of Shareholders’ Equity (Deficit) and (v) related notes.

104*						Cover page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

*Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Sonida Senior Living, Inc

(Registrant)


By:			/s/ BRANDON M. RIBAR
			Brandon M. Ribar
			President, Chief Executive Officer and Director
			(Principal Executive Officer)
			Date: May 10, 2024


By:			/s/ KEVIN J. DETZ
			Kevin J. Detz
			Executive Vice President and Chief Financial Officer
			(Principal Financial Officer)
			Date: May 10, 2024

EXHIBIT 31.1

SONIDA SENIOR LIVING, INC.

CERTIFICATIONS

I, Brandon M. Ribar, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Sonida Senior Living, Inc. (“Registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the Registrant as of, and for, the periods presented in this report;

4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and we have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal controls over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent function):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.


			/s/ BRANDON M. RIBAR
			Brandon M. Ribar
			President and Chief Executive Officer
			(Principal Executive Officer)
			May 10, 2024

EXHIBIT 31.2

SONIDA SENIOR LIVING, INC.

CERTIFICATIONS

I, Kevin J. Detz, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Sonida Senior Living, Inc. (“Registrant”);

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.


			/s/ KEVIN J. DETZ
			Kevin J. Detz
			Executive Vice President and Chief Financial Officer
			(Principal Financial Officer)
			May 10, 2024

EXHIBIT 32.1

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the filing of the Quarterly Report of Sonida Senior Living, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Brandon M. Ribar, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


			/s/ BRANDON M. RIBAR
			Brandon M. Ribar
			President and Chief Executive Officer
			(Principal Executive Officer)
			May 10, 2024

EXHIBIT 32.2

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the filing of the Quarterly Report of Sonida Senior Living, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kevin J. Detz, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


			/s/ KEVIN J. DETZ
			Kevin J. Detz
			Executive Vice President and Chief Financial Officer
			(Principal Financial Officer)
			May 10, 2024

Cover Page - shares	3 Months Ended
Cover Page - shares	Mar. 31, 2024	May 08, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	1-13445
Entity Registrant Name	Sonida Senior Living, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	75-2678809
Entity Address, Address Line One	14755 Preston Road
Entity Address, Address Line Two	Suite 810
Entity Address, City or Town	Dallas
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75254
City Area Code	972
Local Phone Number	770-5600
Title of 12(b) Security	Common Stock, $0.01 par value per share
Trading Symbol	SNDA
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		13,854,520
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Entity Central Index Key	0001043000
Current Fiscal Year End Date	--12-31

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 24,211	$ 4,082
Restricted cash	13,452	13,668
Accounts receivable, net	10,346	8,017
Prepaid expenses and other assets	3,412	4,475
Derivative assets	2,130	2,103
Total current assets	53,551	32,345
Property and equipment, net	581,902	588,179
Other assets, net	824	936
Total assets	636,277	621,460
Current liabilities:
Accounts payable	4,864	11,375
Accrued expenses	39,747	42,388
Current portion of notes payable, net of deferred loan costs	6,831	42,323
Deferred income	4,255	4,041
Federal and state income taxes payable	288	215
Other current liabilities	512	519
Total current liabilities	56,497	100,861
Notes payable, net of deferred loan costs and current portion	571,267	587,099
Other long-term liabilities	40	49
Total liabilities	627,804	688,009
Commitments and contingencies (Note 11)
Redeemable preferred stock:
Series A convertible preferred stock, $0.01 par value; 41 shares authorized, 41 shares issued and outstanding as of March 31, 2024 and December 31, 2023	49,877	48,542
Shareholders’ deficit:
Preferred stock	0	0
Common stock	132	82
Additional paid-in capital	349,610	302,992
Retained deficit	(391,146)	(418,165)
Total shareholders’ deficit	(41,404)	(115,091)
Total liabilities, redeemable preferred stock and shareholders’ deficit	$ 636,277	$ 621,460

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Series A convertible preferred stock , par value (in USD per share)	$ 0.01	$ 0.01
Temporary equity, shares authorized (in shares)	41,000	41,000
Temporary equity, shares issued (in shares)	41,000	41,000
Temporary equity, shares outstanding (in shares)	41,000	41,000
Preferred stock, par value (in USD per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	15,000,000	15,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in USD per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	30,000,000	15,000,000
Common stock, shares issued (in shares)	13,197,000	8,178,000
Common stock, shares outstanding (in shares)	13,197,000	8,178,000

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Total revenues	$ 67,438	$ 62,073
Expenses:
Operating expense	46,317	43,808
General and administrative expense	7,211	7,063
Depreciation and amortization expense	9,935	9,881
Managed community reimbursement expense	6,107	4,962
Total expenses	69,570	65,714
Other income (expense):
Interest income	139	194
Interest expense	(8,591)	(8,867)
Gain on extinguishment of debt, net	38,148	36,339
Other income (expense), net	(479)	189
Income before provision for income taxes	27,085	24,214
Provision for income taxes	(66)	(69)
Net income	27,019	24,145
Undeclared dividends on Series A convertible preferred stock	(1,335)	(1,198)
Less: Undistributed earnings allocated to participating securities	(2,849)	(3,182)
Net income attributable to common stockholders	$ 22,835	$ 19,765
Weighted average common shares outstanding — basic (in shares)	9,861	6,855
Weighted average common shares outstanding — diluted (in shares)	10,562	7,168
Basic net income per common share (in USD per share)	$ 2.32	$ 2.88
Diluted net income per common share (in USD per share)	$ 2.16	$ 2.76
Resident revenue
Revenue from Contract with Customer [Abstract]
Total revenues	$ 60,737	$ 56,606
Management fees
Revenue from Contract with Customer [Abstract]
Total revenues	594	505
Managed community reimbursement revenue
Revenue from Contract with Customer [Abstract]
Total revenues	$ 6,107	$ 4,962

Condensed Consolidated Statements of Shareholders' Equity (Deficit) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands

Total

Common Stock

Additional Paid-In Capital

Retained Deficit

Beginning balance (in shares) at Dec. 31, 2022

6,670

Beginning balance at Dec. 31, 2022

$ (101,714)

$ 67

$ 295,277

$ (397,058)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Undeclared dividends on Series A convertible preferred stock

(1,198)

Stock-based plan activity (in shares)

272

Stock-based plan activity

(15)

$ 2

(17)

Non-cash stock-based compensation

902

Net income

24,145

Ending balance (in shares) at Mar. 31, 2023

6,942

Ending balance at Mar. 31, 2023

(77,880)

$ 69

294,964

(372,913)

Beginning balance (in shares) at Dec. 31, 2023

8,178

Beginning balance at Dec. 31, 2023

(115,091)

$ 82

302,992

(418,165)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Issuance of common stock, net (in shares)

^[1]

5,026

Issuance of common stock, net

^[1]

47,641

$ 50

47,591

Undeclared dividends on Series A convertible preferred stock

(1,335)

Stock-based plan activity (in shares)

(7)

Stock-based plan activity

(213)

Non-cash stock-based compensation

575

Net income

27,019

Ending balance (in shares) at Mar. 31, 2024

13,197

Ending balance at Mar. 31, 2024

$ (41,404)

$ 132

$ 349,610

$ (391,146)

[1]	(1) Issuance of common stock, net includes the shares of common stock with the Company’s recently completed private placement transaction, net of issuance costs.

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net income	$ 27,019	$ 24,145
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	9,935	9,881
Amortization of deferred loan costs	324	366
Gain on sale of assets, net	(192)	(251)
Loss on derivative instruments, net	527	572
Gain on extinguishment of debt	(38,148)	(36,339)
Provision for bad debt	397	237
Non-cash stock-based compensation expense	575	902
Other non-cash items	(3)	(1)
Changes in operating assets and liabilities:
Accounts receivable, net	(2,726)	(48)
Prepaid expenses and other assets	1,063	1,159
Other assets, net	(41)	62
Accounts payable and accrued expense	(3,123)	1,828
Federal and state income taxes payable	73	260
Deferred income	214	438
Other current liabilities	1	38
Net cash provided by (used in) operating activities	(4,105)	3,249
Cash flows from investing activities:
Capital expenditures	(5,762)	(5,429)
Proceeds from sale of assets	631	343
Net cash used in investing activities	(5,131)	(5,086)
Cash flows from financing activities:
Proceeds from notes payable	24,830	0
Repayments of notes payable	(41,999)	(3,714)
Proceeds from issuance of common stock, net	47,641	0
Purchase of interest rate cap	(554)	0
Deferred loan costs paid	(549)	0
Other financing costs	(220)	(45)
Net cash provided by (used in) financing activities	29,149	(3,759)
Increase (decrease) in cash and cash equivalents and restricted cash	19,913	(5,596)
Cash, cash equivalents, and restricted cash at beginning of period	17,750	30,742
Cash, cash equivalents, and restricted cash at end of period	37,663	25,146
Cash paid during the period for:
Interest	6,353	7,639
Income taxes paid (refunds received), net	(7)	(193)
Non-cash investing and financing activities:
Undeclared dividends on Series A convertible preferred stock	1,335	1,198
Non-cash additions of property and equipment	$ 498	$ 1,150

Basis of Presentation	3 Months Ended
Basis of Presentation	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation Organization and Business Sonida Senior Living, Inc. (formerly known as Capital Senior Living Corporation), a Delaware corporation (together with its subsidiaries, the “Company,” “we,” “our,” “us,” or “Sonida”), is one of the leading owner-operators of senior housing communities in the United States in terms of resident capacity. The Company owns, operates, and manages senior housing communities throughout the United States. As of March 31, 2024, the Company operated 71 senior housing communities in 18 states with an aggregate capacity of approximately 8,000 residents, including 61 communities which the Company owned and 10 communities that the Company third-party manages. The accompanying condensed consolidated financial statements include the financial statements of Sonida Senior Living, Inc. and its wholly-owned subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation. Interim Unaudited Financial Information The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and should be read in conjunction with the condensed consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2023. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted from this Quarterly Report on Form 10-Q pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The results for the interim periods shown in this report are not necessarily indicative of future financial results. The accompanying condensed consolidated financial statements have not been audited by our independent registered public accounting firm. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, including normal recurring items, necessary to present fairly our condensed consolidated financial position as of March 31, 2024 and December 31, 2023, and our condensed consolidated results of operations and cash flows for the periods ended March 31, 2024 and 2023. Reclassifications Certain amounts previously reflected in the prior year condensed consolidated financial statements have been reclassified to conform to our March 31, 2024 presentation. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. These estimates include such items related to the accounting for: income taxes, including assessments of probabilities of realization of income tax benefits; impairment of long-lived assets, including applicable cash flow projections, holding periods and fair value evaluations; self-insurance liabilities and expense; stock-based compensation; and depreciation and amortization including determination of estimated useful lives. Actual results could differ from those estimates.

Liquidity	3 Months Ended
Liquidity	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Liquidity	Liquidity During 2023, the Company's liquidity conditions, including operating losses and net working capital deficits, raised substantial doubt about the Company's ability to continue as a going concern. As a result of increases in occupancy occurring throughout 2023 and continuing into 2024, rental rate increases in March 2024 and the 2024 private placement transaction and Protective Life loan purchase, the Company has substantially improved its liquidity position. See “Note 6 –Notes Payable” and “Note 7 –S ecurities Fi nancing” for details of the transactions that have increased cash on hand significantly. In addition, $10.3 million was raised in April 2024 through our at-the-market equity offering. See “Note 15 –Sub sequent Events.” Based on these events, the Company concluded it has adequate cash to meet its obligations as they become due for the 12-month period following the date the March 31, 2024 financial statements are issued.

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Cash, Cash Equivalents, and Restricted Cash

The following table sets forth our cash, cash equivalents, and restricted cash (in thousands):


	March 31, 2024		December 31, 2023
Cash and cash equivalents	$	24,211	$	4,082
Restricted cash:
Property tax and insurance reserves	5,339		7,237
Lender reserves	4,665		3,329
Capital expenditures reserves	2,714		2,060
Escrow deposit	500		1,000
Deposits pursuant to outstanding letters of credit	42		42
Other reserves	192		—
Total restricted cash	13,452		13,668
Total cash, cash equivalents, and restricted cash	$	37,663	$	17,750

Long-Lived Assets

Revenue Recognition

Credit Risk and Allowance for Doubtful Accounts

Concentration of Credit Risk and Business Risk

Self-Insurance Liability Accruals

Income Taxes

The Company is evaluating the potential tax impact of the Protective Life Insurance Company gain on extinguishment of debt totaling $38.1 million.

Redeemable Preferred Stock

Derivative Instruments

Net Income Per Common Share

Segment Reporting

Troubled Debt Restructurings

Recently Issued Accounting Pronouncements Not Yet Adopted

Improvements to Reportable Segment Disclosures

within fiscal years beginning after December 15, 2024. We are currently evaluating the impact of this guidance on the disclosures within the Company's condensed consolidated financial statements.

Improvements to Income Tax Disclosures

Property and Equipment, net

3 Months Ended

Mar. 31, 2024

Property, Plant and Equipment [Abstract]

Property and Equipment, net

As of March 31, 2024 and December 31, 2023, property and equipment, net, which include assets under finance leases, consist of the following (in thousands):


	Asset Lives	March 31, 2024		December 31, 2023
Land		$	46,806	$	47,173
Land improvements	5 to 20 years	20,621		20,487
Buildings and building improvements	10 to 40 years	848,055		845,873
Furniture and equipment	5 to 10 years	59,081		58,443
Automobiles	5 to 7 years	2,696		2,687
Assets under financing leases and leasehold improvements (1)		3,361		2,766
Construction in progress		583		259
Total property and equipment		$	981,203	$	977,688
Less accumulated depreciation and amortization		(399,301)		(389,509)
Total property and equipment, net		$	581,902	$	588,179

__________

There were no impairments on long-lived assets for the three months ended March 31, 2024 and 2023.

Accrued Expenses

3 Months Ended

Mar. 31, 2024

Payables and Accruals [Abstract]

Accrued Expenses

The following is a summary of accrued expenses as of March 31, 2024 and December 31, 2023 (in thousands):


	March 31, 2024		December 31, 2023
Accrued payroll and employee benefits	$	16,721	$	15,639
Accrued interest (1)	9,194		11,316
Accrued taxes	5,489		7,614
Accrued professional fees	5,625		5,022
Accrued other expenses	2,718		2,797
Total accrued expenses	$	39,747	$	42,388

__________

(1) Includes deferred interest of $5.9 million and $4.3 million as of March 31, 2024 and December 31, 2023, respectively, in consideration of the Fannie Mae Loan Modification (as defined below).

Notes Payable

3 Months Ended

Mar. 31, 2024

Debt Disclosure [Abstract]

Notes Payable

Notes payable consists of the following (in thousands):


	Weighted average interest rate	Maturity Date	March 31, 2024		December 31, 2023
Fixed rate mortgage notes payable	4.6%	2025 to 2045	$	418,275	$	492,998
Variable rate mortgage notes payable (1)	6.3%	2026 to 2029	162,114		137,320
Notes payable - insurance	6.3%	2024	854		1,846
Notes payable - other	8.5%	2024	1,213		1,619
Notes payable			$	582,456	$	633,783
Deferred loan costs, net			4,358		4,361
Total notes payable, net of deferred loan costs			$	578,098	$	629,422
Current portion of notes payable			6,831		42,323
Long-term notes payable, net			$	571,267	$	587,099

_____________

(1) See Note 14 for interest rate cap agreements on variable rate mortgage notes payable.

The following schedule summarizes our notes payable as of March 31, 2024 (in thousands):


Principal payments due in:
2024	$	8,075
2025	31,434
2026	335,214
2027	3,597
2028	3,719
Thereafter	200,417
Total notes payable, excluding deferred loan costs	$	582,456

As of March 31, 2024, we had property and equipment with a net carrying value of $565.5 million that is secured by outstanding notes payable.

Protective Life Insurance Company Loan Repurchase Agreement and Ally Term Loan Expansion

Fannie Mae Loan Modification

The Company entered into Loan Modification Agreements with Fannie Mae on October 2, 2023. The material terms of the Loan Modification Agreements were as follows:

•Maturities on 18 community mortgages, ranging from July 2024 to December 2026, were extended to December 2026. The remaining 19 communities under the MCF have existing maturities in January 2029.

Transactions Involving Certain Fannie Mae Loans

2024 Ally Loan Amendment

2023 Ally Loan Amendment

•Subsequent to the Waiver period, all funds in the Waiver Principal Reserve Account as well as any funds swept into the Equity Cure Fund will be released to the Company.

Notes Payable - Insurance

Other Debt Transactions

Debt Covenant Compliance

The Company was in compliance with its debt covenants related to its outstanding indebtedness as of March 31, 2024.

Securities Financing	3 Months Ended
Securities Financing	Mar. 31, 2024
Equity [Abstract]
Securities Financing	Securities Financing Increase in Authorized Shares of Common Stock On March 21, 2024, following receipt of stockholder approval at the Special Meeting of the Company’s stockholders held on March 21, 2024, the Company filed an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, with the Delaware Secretary of State to increase the number of authorized shares of the Company’s common stock from 15,000,000 shares to 30,000,000 shares (the “Stockholder Approval”). The charter amendment became effective upon filing. 2024 Private Placement Transaction On February 1, 2024, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with Conversant Dallas Parkway (A) LP, Conversant Dallas Parkway (B) LP and several other shareholders (together, the “Investors”), pursuant to which the Investors agreed to purchase from the Company, and the Company agreed to sell to the Investors, in a private placement transaction (the “2024 Private Placement”) pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), an aggregate of 5,026,318 shares of the Company’s common stock at a price of $9.50 per share. The 2024 Private Placement occurred in two tranches. The first tranche occurred on February 1, 2024, at which time 3,350,878 shares of common stock were issued and sold to the Investors for $31.8 million. The second tranche occurred on March 22, 2024, at which time 1,675,440 shares of common stock were issued and sold to the Investors for $15.9 million. The Company used a portion of the proceeds from the first closing of the 2024 Private Placement to fund a portion of the cash purchase price for the Protective Life Loan Purchase and the Company intends to use the remaining proceeds for ongoing working capital, continued investments in community improvements, potential acquisitions of new communities, broader community programming and general corporate purposes. As of March 22, 2024, the majority of our common stock is held by Conversant Dallas Parkway (A) LP, Conversant Dallas Parkway (B) LP, and Conversant Dallas Parkway (D) LP (together, “Conversant” or the “Conversant Investors”). Series A Preferred Stock In November 2021, the Company issued 41,250 shares of Series A Preferred Stock. The Series A Preferred Stock is convertible outside of the Company's control and, in accordance with GAAP, is classified as mezzanine equity, outside the stockholders’ equity (deficit) section, on our condensed consolidated balance sheets. The Series A Preferred Stock has an 11% annual dividend calculated on the original investment of approximately $41.3 million accrued quarterly in arrears and compounded. Dividends are cumulative, and any declaration of dividends is at the discretion of the Company’s Board of Directors. If the Board does not declare a dividend in respect of any dividend payment date, the amount of such accrued and unpaid dividend is added to the liquidation preference and compounds quarterly thereafter. On March 31, 2024, the Board did not declare dividends with respect to the Series A Preferred Stock, and accordingly, $1.3 million was added to the liquidation preference of the Series A Preferred Stock, effectively increasing the carrying value of the Series A Preferred Stock. As of March 31, 2024, a total of $8.6 million has been added to the liquidation preference of the Series A Preferred Stock. Conversant Equity Commitment In connection with the Fannie Forbearance and 2023 Ally Amendment signed on June 29, 2023, the Company entered into a $13.5 million equity commitment agreement (“Equity Commitment”) with Conversant for a term of 18 months. Sonida has the right, but not the obligation, to utilize Conversant’s equity commitment and may draw on the commitment in whole or in part, subject to the terms and conditions therein and applicable laws and regulations. As of March 31, 2024, the Company had $3.5 million remaining under its Equity Commitment with Conversant, and the Equity Commitment is in effect through December 31, 2024. At-the-Market Equity Offerings See “Note 15 –Subsequent Even t s” for the Company’s At-the-Market Issuance Sales Agreement entered into on April 1, 2024 and subsequent equity issuances.

Revenue

3 Months Ended

Mar. 31, 2024

Revenue from Contract with Customer [Abstract]

Revenue

Revenue for the three months ended March 31, 2024 and 2023 is comprised of the following components (in thousands):


	Three Months Ended March 31,
		2024		2023
Housing and support services		$	59,984	$	53,791
Community fees		459		479
Ancillary services		294		273
Other operating revenue (1)		—		2,063
Resident revenue		60,737		56,606
Management fees		594		505
Managed community reimbursement revenue		6,107		4,962
Total revenues		$	67,438	$	62,073

__________

Community fees, ancillary services, management fees, and community reimbursement revenue represent revenue from contracts with customers in accordance with GAAP.

Net Income Per Share

3 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Net Income Per Share

dilutive securities. The Series A Preferred Stock is considered participating securities for the purposes of the Company's EPS calculation.

The following table sets forth the computation of basic and diluted net income per share (in thousands, except for per share amounts):


	Three Months Ended March 31,
		2024		2023
Basic net income per common share calculation:
Net income		$	27,019	$	24,145

Less: Undeclared dividends on Series A Preferred Stock		(1,335)		(1,198)
Less: Undistributed earnings allocated to participating securities		(2,849)		(3,182)
Net income attributable to common stockholders		$	22,835	$	19,765
Weighted average shares outstanding — basic		9,861		6,855
Basic net income per share		$	2.32	$	2.88

Diluted net income per common share calculation:
Net income attributable to common stockholders		$	22,835	$	19,765
Weighted average shares outstanding — diluted		10,562		7,168
Diluted net income per share		$	2.16	$	2.76

The following weighted-average shares of securities were not included in the computation of diluted net income per common share as their effect would have been antidilutive:


	Three Months Ended March 31,
(shares in thousands)		2024	2023
Warrants		1,031	1,031
Series A Preferred Stock (if converted)		1,230	1,104
Restricted stock awards		22	190

Stock options		10	10
Total		2,293	2,335

Stock-Based Compensation	3 Months Ended
Stock-Based Compensation	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation The Company’s uses equity awards as a long-term retention program that is intended to attract, retain and provide incentives for employees, officers, and directors and to more closely align stockholder and employee interests. The Company recognizes compensation expense for all of its share-based stock awards based on their fair values. The Company recognized $0.6 million and $0.9 million in stock-based compensation expense for the three months ended March 31, 2024 and March 31, 2023, respectively.

Commitments and Contingencies	3 Months Ended
Commitments and Contingencies	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies As of March 31, 2024, the Company had contractual commitments of $3.1 million related to future renovations and technology enhancements to its communities, which are expected to be substantially expended during 2024. The Company has claims incurred in the normal course of its business. Most of these claims are believed by management to be covered by insurance, subject to deductibles, normal reservations of rights by the insurance companies and possibly subject to certain exclusions in the applicable insurance policies. Whether or not covered by insurance, these claims, in the opinion of management, based on advice of legal counsel, should not have a material impact on the condensed consolidated financial statements of the Company.

Related Party Transactions	3 Months Ended
Related Party Transactions	Mar. 31, 2024
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions As of March 31, 2024, Conversant and its affiliates beneficially owned approximately 61% of our outstanding shares of common stock (inclusive of common stock issuable upon conversion of outstanding Series A Preferred Stock and outstanding warrants). During the three months ended March 31, 2024, the Conversant Investors purchased an additional 3,157,895 shares of common stock of the Company for $30.0 million. See “Note 7–Securities Financing.”

Fair Value Measurements

3 Months Ended

Mar. 31, 2024

Fair Value Disclosures [Abstract]

Fair Value Measurements

Assets and Liabilities Measured at Fair Value on a Recurring Basis

Financial Instruments Not Reported at Fair Value


	March 31, 2024				December 31, 2023
	Carrying Amount		Fair Value		Carrying Amount		Fair Value


Cash and cash equivalents	$	24,211	$	24,211	$	4,082	$	4,082
Restricted cash	13,452		13,452		13,668		13,668
Notes payable, excluding deferred loan costs	$	582,456	$	538,271	$	633,783	$	597,266

We believe the carrying amount of cash and cash equivalents, restricted cash, accounts receivable, and accounts payable, and accrued expenses approximate fair value due to their short-term nature.

Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis

Derivatives and Hedging

3 Months Ended

Mar. 31, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivatives and Hedging

The following table presents the fair values of derivative assets and liabilities in the condensed consolidated balance sheets (in thousands):


	March 31, 2024
	Derivative Asset				Derivative Liability
	Notional Amount		Fair Value		Notional Amount		Fair Value

Interest rate cap (SOFR-based)	$	112,955	$	2,130	$	—	$	—
Total derivatives, net	$	112,955	$	2,130	$	—	$	—


	December 31, 2023
	Derivative Asset				Derivative Liability
	Notional Amount		Fair Value		Notional Amount		Fair Value

Interest rate cap (SOFR-based)	$	138,385	$	2,103	$	—	$	—
Total derivatives, net	$	138,385	$	2,103	$	—	$	—

The following table presents the effect of the derivative instruments on the condensed consolidated statements of operations (in thousands):



	Three months ended March 31,
		2024		2023
Derivative not designated as hedge
Interest rate cap
Loss on derivatives not designated as hedges included in interest expense		$	(527)	$	(572)

Subsequent Events	3 Months Ended
Subsequent Events	Mar. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events At-the Market Equity Offerings On April 1, 2024, the Company entered into an At-the-Market Issuance Sales Agreement (the “ATM Sales Agreement”) with Mizuho Securities USA LLC, who is acting as the sole sales agent (the “Agent”). Pursuant to the ATM Sales Agreement, the Company may sell, at its option, shares of its common stock up to an aggregate offering price of $75,000,000 (the “Shares”) through the Agent. Sales of the Shares made pursuant to the ATM Sales Agreement, if any, will be made under the Company’s Registration Statement on Form S-3 filed with the SEC on May 1, 2023 (File No. 333-271545), which includes a base prospectus and was declared effective on May 9, 2023 (the “Registration Statement”), and the prospectus supplement dated April 1, 2024 relating to the offering and filed with the SEC on April 1, 2024 (the “Prospectus Supplement”), in each case, as may be amended or supplemented from time to time. Subject to the terms and conditions of the ATM Sales Agreement, the Company may propose that the Agent place Shares pursuant to the terms set forth in a placement notice (each, a “Transaction”). The Agent may sell the Shares, if any, in a Transaction only by methods deemed to be an “at the market offering” as defined in Rule 415 promulgated under the Securities Act, including without limitation sales made directly on The New York Stock Exchange, on any other trading market for the common stock or to or through a market maker. In addition, the Agent may, with the Company’s prior written consent, sell Shares by any other method permitted by law, including negotiated transactions. The Agent will use commercially reasonable efforts consistent with its normal trading and sales practices to sell the Shares in a Transaction in accordance with the terms of the ATM Sales Agreement and any applicable placement notice. The ATM Sales Agreement provides that the Agent will be entitled to receive a commission of up to 3% of the gross proceeds from the sale of the Shares in a Transaction. Pursuant to the terms of the ATM Sales Agreement, the Company also provided the Agent with customary indemnification and contribution rights. The offering of common stock pursuant to the ATM Sales Agreement will terminate upon the earlier of, among other things, (i) the sale of all of the Shares subject to the ATM Sales Agreement and (ii) the termination of the ATM Sales Agreement by the Company or by the Agent, following delivery of sufficient written notice by the Company or the Agent to the other party. The Company cannot provide any assurances that it will issue any additional Shares pursuant to the ATM Sales Agreement. The Company currently anticipates that the net proceeds from the sale of the Shares offered pursuant to the ATM Sales Agreement, if any, will be used for potential acquisition opportunities, capital expenditure projects at the Company’s senior living communities, working capital and other general corporate purposes. See “Item 6. Exhibits.” On April 5, 2024, the Company sold 382,000 shares pursuant to the ATM Sales Agreement at $27.50 per share for net proceeds of $10.3 million, inclusive of $0.2 million in commissions paid to its Agent. The Company cannot provide any assurances that it will issue any additional shares of common stock pursuant to the ATM Sales Agreement. Derivative Purchase During April 2024, the Company entered into an interest rate cap transaction for an aggregate notional amount of $49.2 million for $1.1 million to reduce exposure to interest rate fluctuations associated with a portion of our variable mortgage notes payable to Fannie Mae. The interest rate cap has 24-month term and effectively caps SOFR at 4.00% from April 1, 2024 through April 1, 2026 with respect to such floating rate indebtedness. In the event SOFR is less than the capped rate, we will pay interest at the lower SOFR rate. In the event SOFR is higher than the capped rate, we will pay interest at the capped rate of 4.00% plus the applicable margin. The Company is funding an IRC reserve for a replacement IRC which is held by the lender. Macedonia Acquisition In April 2024, the Company entered into an asset purchase agreement to acquire a community located in Macedonia, Ohio and all in-place leases for a purchase price totaling $10.7 million that closed on May 9, 2024. In conjunction with the closing, the Company entered into a mortgage loan totaling $9.4 million. The Company also entered into a SOFR-based interest rate cap to reduce exposure to the variable interest rate fluctuations associated with the new mortgage. The total cost of the IRC was $0.2 million and has an aggregate notional amount of $9.4 million. The IRC has a 24-month term and effectively caps SOFR at 6.00% from May 9, 2024 through May 1, 2026 with respect to such floating rate indebtedness. Management Agreement Letter of Intent During March 2024, the Company received a Non-Binding Letter of Intent from a public Real Estate Investment Trust in which the Company would manage three properties in exchange for a management fee. The transition of the three properties is anticipated to occur on June 1, 2024. The completion of this potential transaction is subject to several conditions, including the completion of satisfactory due diligence and the negotiation and execution of definitive management agreements. Accordingly, there can be no assurance that this potential transaction will be completed upon the terms or dates contemplated, if at all.

Summary of Significant Accounting Policies (Policies)	3 Months Ended
Summary of Significant Accounting Policies (Policies)	Mar. 31, 2024
Accounting Policies [Abstract]
Reclassifications	Reclassifications Certain amounts previously reflected in the prior year condensed consolidated financial statements have been reclassified to conform to our March 31, 2024 presentation.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. These estimates include such items related to the accounting for: income taxes, including assessments of probabilities of realization of income tax benefits; impairment of long-lived assets, including applicable cash flow projections, holding periods and fair value evaluations; self-insurance liabilities and expense; stock-based compensation; and depreciation and amortization including determination of estimated useful lives. Actual results could differ from those estimates.
Cash, Cash Equivalents, and Restricted Cash	Cash, Cash Equivalents, and Restricted Cash The Company considers all highly liquid investments with original maturities of three months or less at the date of acquisition to be cash equivalents. The Company has deposits in banks that exceed Federal Deposit Insurance Corporation insurance limits. Management believes that credit risk related to these deposits is minimal. Restricted cash consists of reserve accounts for property insurance, real estate taxes, capital expenditures, derivatives, and debt service required by certain loan agreements. In addition, restricted cash includes deposits required by certain counterparties as collateral pursuant to letters of credit which must remain so long as the letters of credit are outstanding, which are subject to renewal annually
Long-Lived Assets	Long-Lived Assets Property and equipment are stated at cost and depreciated on a straight-line basis over the estimated useful lives of the assets. At each balance sheet date, the Company reviews the carrying value of its property and equipment to determine if facts and circumstances suggest that they may be impaired or that the depreciation period may need to be changed. The Company considers internal factors such as net operating losses along with external factors relating to each asset, including contract changes, local market developments, and other publicly available information to determine whether impairment indicators exist. If an indicator of impairment is identified, recoverability of an asset group is assessed by comparing its carrying amount to the estimated future undiscounted net cash flows expected to be generated by the asset group through operation or disposition, calculated utilizing the lowest level of identifiable cash flows. If this comparison indicates that the carrying amount of an asset group is not recoverable, the Company estimates fair value of the asset group and records an impairment loss when the carrying amount exceeds fair value. There were no impairments on long-lived assets during the three months ended March 31, 2024 and 2023. In evaluating our long-lived assets for impairment, we undergo continuous evaluations of property level performance and real estate trends, and management makes several estimates and assumptions, including, but not limited to, the projected date of disposition, estimated sales price, and future cash flows of each property during our estimated holding period. If our analysis or assumptions regarding the projected cash flows expected to result from the use and eventual disposition of our properties change, we incur additional costs and expenses during the holding period, or our expected hold periods change, we may incur future impairment losses. Upon the acquisition of new communities accounted for as an acquisition of assets, we recognize the assets acquired and the liabilities assumed as of the acquisition date, measured at their relative fair values once we have determined the fair value of each of these assets and liabilities. The acquisition date is the date on which we obtain control of the real estate property. The assets acquired and liabilities assumed consist of land, inclusive of associated rights, buildings, assumed debt, and identified intangible assets and liabilities.
Revenue Recognition	Revenue Recognition Resident revenue consists of fees for basic housing and certain support services and fees associated with additional housing and expanded support requirements such as assisted living care, memory care, and ancillary services. Basic housing and certain support services revenue is recorded when services are rendered, and amounts billed are due from residents in the period in which the rental and other services are provided. Residency agreements are generally short term in nature with durations of one year or less and are typically terminable by either party, under certain circumstances, upon providing 30 days’ notice, unless state law provides otherwise, with resident fees billed monthly in advance. Revenue for certain ancillary services is recognized as services are provided, and includes fees for services such as medication management, daily living activities, beautician/barber, laundry, television, guest meals, pets, and parking, which are generally billed monthly in arrears. Other operating revenue consists of state relief funds received from various states due to the financial distress impacts of COVID-19 (“State Relief Funds”). The Company’s senior housing communities have residency agreements that generally require the resident to pay a community fee and other amounts prior to moving into the community, which are initially recorded by the Company as deferred revenue. The Company had contract liabilities for deferred fees paid by our residents prior to the month housing and support services were to be provided totaling approximately $4.3 million and $4.0 million, respectively, which is reported as deferred income within current liabilities of the Company’s condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023. Revenues from the Medicaid program accounted for 11.6% and 9.3% of the Company’s revenue in the three months ended March 31, 2024 and 2023, respectively. During the three months ended March 31, 2024 and 2023, 22 and 24, respectively, of the Company’s communities were providers of services under the Medicaid program. Accordingly, these communities were entitled to reimbursement under the Medicaid program at established rates that were lower than private pay rates. Resident revenues for Medicaid residents were recorded at the reimbursement rates as the rates were set prospectively by the applicable state upon the filing of an annual cost report. None of the Company’s communities were providers of services under the Medicare program during the three months ended March 31, 2024 and 2023. Laws and regulations governing the Medicaid program are complex and subject to interpretation. The Company believes that it is in compliance with all applicable laws and regulations and is not aware of any pending or threatened investigations involving allegations of potential wrongdoing that would have a material effect on its Condensed Consolidated Financial Statements. While no such regulatory inquiries have been made, compliance with such laws and regulations can be subject to future government review and interpretation as well as significant regulatory action including fines, penalties, and exclusion from the Medicaid program. The Company has management agreements whereby it manages certain communities on behalf of third-party owners under contracts that provide for periodic management fee payments to the Company. The Company has determined that all community management activities are a single performance obligation, which is satisfied over time as the services are rendered. The Company’s estimate of the transaction price for management services also includes the amount of reimbursement due from the owners of the communities for services provided and related costs incurred. Such revenue is included in “managed community reimbursement revenue” on the Company’s condensed consolidated statements of operations. The related costs are included in “managed community reimbursement expense” on the Company’s condensed consolidated statements of operations. See “Note 8–Revenue.” For the three months ended March 31, 2023, the Company received approximately $2.0 million in various State Relief Funds from state departments due to financial distress impacts of COVID-19. For the three months ended March 31, 2024, no State Relief Funds were received from the state departments. The Company recognizes income for government grants on a systematic and rational basis over the periods in which the Company recognizes the related expenses or loss of revenue for which the grants are intended to compensate when there is reasonable assurance that the Company will comply with the applicable terms and conditions of the grant and there is reasonable assurance that the grant will be received. The State Relief Funds were recorded as “resident revenue–other operating revenue” in the Company’s condensed statements of operations and notes thereto.
Credit Risk and Allowance for Doubtful Accounts	Credit Risk and Allowance for Doubtful Accounts The Company’s resident accounts receivable are generally due within 30 days after the date billed. Accounts receivable are reported net of an allowance for doubtful accounts of $5.7 million and $5.3 million as of March 31, 2024 and December 31, 2023, respectively, and represent the Company’s estimate of the amount that ultimately will be collected. The adequacy of the Company’s allowance for doubtful accounts is reviewed on an ongoing basis, using historical payment trends, write-off experience, analyses of receivable portfolios by payor source and aging of receivables, as well as a review of specific accounts, and adjustments are made to the allowance, as necessary. Credit losses on resident receivables have historically been within management’s estimates, and management believes that the allowance for doubtful accounts adequately provides for expected losses.
Concentration of Credit Risk and Business Risk	Concentration of Credit Risk and Business Risk Substantially all of our revenues are derived from senior living communities we own and senior living communities that we manage. Senior living operations are particularly sensitive to adverse economic, social and competitive conditions and trends, including the effects of the COVID-19 pandemic, which has adversely affected, and may continue to adversely affect, our business, financial condition, and results of operations.
Self-Insurance Liability Accruals	Self-Insurance Liability Accruals The Company offers full-time employees an option to participate in its health and dental plans. The Company is self-insured up to certain limits and is insured if claims in excess of these limits are incurred. The cost of employee health and dental benefits, net of employee contributions, is shared between the corporate office and the senior housing communities based on the respective number of plan participants. Funds collected are used to pay the actual program costs, including estimated annual claims, third-party administrative fees, network provider fees, communication costs, and other related administrative costs incurred by the plans. Claims are paid as they are submitted to the Company’s third-party administrator. The Company records a liability for outstanding claims and claims that have been incurred but not yet reported. This liability is based on the historical claim reporting lag and payment trends of health insurance claims. Management believes that the recorded liabilities and reserves established for outstanding losses and expenses are adequate to cover the ultimate cost of losses and expenses incurred as of March 31, 2024. It is possible that actual claims and expenses may differ from established reserves. Any subsequent changes in estimates are recorded in the period in which they are determined. The Company uses a combination of insurance and self-insurance for workers’ compensation. Determining the reserve for workers’ compensation losses and costs that the Company has incurred as of the end of a reporting period involves significant judgments based on projected future events, including among other factors, potential settlements for pending claims, known incidents which may result in claims, estimates of incurred but not yet reported claims, changes in insurance premiums and estimated litigation costs. The Company regularly adjusts these estimates to reflect changes in the foregoing factors. However, since this reserve is based on estimates, it is possible the actual expenses incurred may differ from the amounts reserved. Any subsequent changes in estimates are recorded in the period in which they are determined.
Income Taxes	Income Taxes Income taxes are computed using the asset and liability method and current income taxes are recorded based on amounts refundable or payable in the current year. The effective tax rates for the three months ended March 31, 2024 and 2023 differ from the statutory tax rates due to state income taxes, permanent tax differences, and changes in the deferred tax asset valuation allowance. Deferred income taxes are recorded based on the estimated future tax effects of loss carryforwards and temporary differences between financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates that are expected to apply to taxable income in the years in which the Company expects those carryforwards and temporary differences to be recovered or settled. Management regularly evaluates the future realization of deferred tax assets and provides a valuation allowance, if considered necessary, based on such evaluation. As part of the evaluation, management has evaluated taxable income in carryback years, future reversals of taxable temporary differences, feasible tax planning strategies, and future expectations of income. The valuation allowance reduces the Company’s net deferred tax assets to the amount that is “more likely than not” (i.e., a greater than 50% likelihood) to be realized. However, in the event that the Company were to ultimately determine that it would be more likely than not that the Company would realize the benefit of deferred tax assets in the future in excess of their net recorded amounts, adjustments to deferred tax assets would increase net income in the period such determination was made. The benefits of the net deferred tax assets might not be realized if actual results differ from expectations. The Company evaluates uncertain tax positions through consideration of accounting and reporting guidance on criteria, measurement, derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition that is intended to provide better financial statement comparability among different companies. The Company is required to recognize a tax benefit in its financial statements for an uncertain tax position only if management’s assessment is that its position is “more likely than not” (i.e., a greater than 50 percent likelihood) to be upheld on audit based only on the technical merits of the tax position. The Company’s policy is to recognize interest related to unrecognized tax benefits as interest expense and penalties as income tax expense. The Company filed for an employee retention credit (“ERC”) with the Internal Revenue Service in November 2023. The ERC is a tax credit for businesses that had employees and were affected during the COVID-19 pandemic. We have not received any funds from the ERC as of March 31, 2024. The Company is evaluating the potential tax impact of the Protective Life Insurance Company gain on extinguishment of debt totaling $38.1 million.
Redeemable Preferred Stock	Redeemable Preferred Stock The Company's Series A Preferred Stock is convertible outside of our control and is classified as mezzanine equity. The Series A Preferred Stock was initially recorded at fair value upon issuance, net of issuance costs and discounts. The holders, or Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP (together, the “Conversant Preferred Investors”), of Series A Preferred Stock are entitled to vote with the holders of common stock on all matters submitted to a vote of stockholders of the Company. As such, the Conversant Preferred Investors, in combination with their common stock ownership as of March 31, 2024 and December 31, 2023, have voting rights in excess of 50% of the Company’s total voting stock. It is deemed probable that the Series A Preferred Stock could be redeemed for cash by the Conversant Preferred Investors, and as such, the Series A Preferred Stock is required to be remeasured and adjusted to its maximum redemption value at the end of each reporting period. However, to the extent that the maximum redemption value of the Series A Preferred Stock does not exceed the fair value of the shares at the date of issuance, the shares are not adjusted below the fair value at the date of issuance. As of March 31, 2024 and December 31, 2023, the Series A Preferred Stock is carried at the maximum redemption value. The Series A Preferred Stock does not have a maturity date and, therefore, is considered perpetual. Dividends on redeemable Series A Preferred Stock are recorded to retained earnings or additional paid-in capital if retained earnings is an accumulated deficit. Dividends are cumulative, and any declaration of dividends is at the discretion of the Company’s Board of Directors (the “Board”). If the Board does not declare a dividend in respect of any dividend payment date, the amount of such accrued and unpaid dividend is added to the liquidation preference of the Series A Preferred Stock and compounds quarterly thereafter. During the three months ended March 31, 2024, the Board did not declare any dividends with respect to the Series A Preferred Stock, and accordingly, an aggregate of $1.3 million was added to the liquidation preference of the Series A Preferred Stock during such period, effectively increasing the carrying value of the redeemable preferred stock.
Derivative Instruments	Derivative Instruments We use derivative instruments as part of our overall strategy to manage our exposure to market risks associated with the fluctuations in interest rates. We are also required to enter into interest rate derivative instruments in compliance with certain debt agreements. We regularly monitor the financial stability and credit standing of the counterparties to our derivative instruments. We do not enter into derivative financial instruments for trading or speculative purposes. We record all derivatives at fair value. As of March 31, 2024 and December 31, 2023, our derivative instruments consisted of interest rate caps that were not designated as hedge instruments. Changes in fair value of undesignated hedge instruments are recorded in current period earnings as interest expense.
Net Income Per Common Share	Net Income Per Common Share The Company uses the two-class method to compute net income per common share because the Company has issued securities (Series A Preferred Stock) that entitle the holder to participate in dividends and earnings of the Company. Under this method, net income is reduced by the amount of any dividends earned during the period. The remaining earnings (undistributed earnings) are allocated based on the weighted-average shares outstanding of common stock and Series A Preferred Stock (on an if-converted basis) to the extent that each preferred security may share in earnings as if all of the earnings for the period had been distributed. The total earnings allocated to common stock is then divided by the number of outstanding shares to which the earnings are allocated to determine the earnings per share. The two-class method is not applicable during periods with a net loss, as the holders of the Series A Preferred Stock have no obligation to fund losses. Diluted net income per common share is computed under the two-class method by using the weighted-average number of shares of common stock outstanding, plus, for periods with net income attributable to common stockholders, the potential dilutive effects of stock options, stock-based compensation awards, and warrants. In addition, the Company analyzes the potential dilutive effect of the outstanding Series A Preferred Stock under the "if-converted" method when calculating diluted earnings per share, in which it is assumed that the outstanding Series A Preferred Stock converts into common stock at the beginning of the period or when issued, if later. The Company reports the more dilutive of the approaches (two class or "if-converted") as its diluted net income per share during the period.
Segment Reporting	Segment Reporting The Company evaluates the performance and allocates resources of its senior living communities based on current operations and market assessments on a property-by-property basis. The Company does not have a concentration of operations geographically or by product or service as its management functions are integrated at the property level. The Company has determined that its operating units meet the criteria in Accounting Standards Codification (“ASC”) Topic 280, Segment Reporting, to be aggregated into one reporting segment. As such, the Company operates in one segment.
Troubled Debt Restructurings	Troubled Debt Restructurings The Company assesses all loan modifications with existing lenders to determine if it is a troubled debt restructuring. A loan that has been modified or renewed is considered to be a troubled debt restructuring when two conditions are met: (1) the borrower is experiencing financial difficulty and (2) concessions are made for the borrower’s benefit that would not otherwise be considered for a borrower or a transaction with similar credit risk characteristics. These concessions may include modifications of the terms of the debt such as deferral of payments, extension of maturity, reduction of principal balance, reduction of the stated interest rate other than normal market rate adjustments, or a combination of these concessions. The Company compares the total cash outflows of the restructured debt to the carrying amount of the debt prior to the restructure. If cash outflows of the restructured debt are less than the carrying amount, a gain is recognized and the carrying amount of the debt is adjusted. If cash outflows of the restructured debt are more than the carrying amount, no gain or loss is recognized and the carrying amount of the debt is not adjusted. The change in cash outflows resulting from the restructuring is accounted for on a prospective basis by calculating a new effective interest rate on the restructured debt and applying it to recognize lower interest expense over the remaining term.
Recently Issued Accounting Pronouncements Not Yet Adopted	Recently Issued Accounting Pronouncements Not Yet Adopted Improvements to Reportable Segment Disclosures In November of 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments are intended to increase reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. The ASU is effective on a retrospective basis for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. We are currently evaluating the impact of this guidance on the disclosures within the Company's condensed consolidated financial statements. Improvements to Income Tax Disclosures In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments require disclosure of specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold and further disaggregation of income taxes paid for individually significant jurisdictions. The ASU is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. We are currently evaluating the impact that this guidance will have on the disclosures within the Company's condensed consolidated financial statements.

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Schedule of Cash and Cash Equivalents and Restricted Cash

The following table sets forth our cash, cash equivalents, and restricted cash (in thousands):


	March 31, 2024		December 31, 2023
Cash and cash equivalents	$	24,211	$	4,082
Restricted cash:
Property tax and insurance reserves	5,339		7,237
Lender reserves	4,665		3,329
Capital expenditures reserves	2,714		2,060
Escrow deposit	500		1,000
Deposits pursuant to outstanding letters of credit	42		42
Other reserves	192		—
Total restricted cash	13,452		13,668
Total cash, cash equivalents, and restricted cash	$	37,663	$	17,750

Property and Equipment, net (Tables)

3 Months Ended

Mar. 31, 2024

Property, Plant and Equipment [Abstract]

Schedule of Net Property and Equipment and Leasehold Improvements

As of March 31, 2024 and December 31, 2023, property and equipment, net, which include assets under finance leases, consist of the following (in thousands):


	Asset Lives	March 31, 2024		December 31, 2023
Land		$	46,806	$	47,173
Land improvements	5 to 20 years	20,621		20,487
Buildings and building improvements	10 to 40 years	848,055		845,873
Furniture and equipment	5 to 10 years	59,081		58,443
Automobiles	5 to 7 years	2,696		2,687
Assets under financing leases and leasehold improvements (1)		3,361		2,766
Construction in progress		583		259
Total property and equipment		$	981,203	$	977,688
Less accumulated depreciation and amortization		(399,301)		(389,509)
Total property and equipment, net		$	581,902	$	588,179

__________

Accrued Expenses (Tables)

3 Months Ended

Mar. 31, 2024

Payables and Accruals [Abstract]

Schedule of Accounts Payable and Accrued Liabilities

The following is a summary of accrued expenses as of March 31, 2024 and December 31, 2023 (in thousands):


	March 31, 2024		December 31, 2023
Accrued payroll and employee benefits	$	16,721	$	15,639
Accrued interest (1)	9,194		11,316
Accrued taxes	5,489		7,614
Accrued professional fees	5,625		5,022
Accrued other expenses	2,718		2,797
Total accrued expenses	$	39,747	$	42,388

__________

(1) Includes deferred interest of $5.9 million and $4.3 million as of March 31, 2024 and December 31, 2023, respectively, in consideration of the Fannie Mae Loan Modification (as defined below).

Notes Payable (Tables)

3 Months Ended

Mar. 31, 2024

Debt Disclosure [Abstract]

Schedule of Notes Payable

Notes payable consists of the following (in thousands):


	Weighted average interest rate	Maturity Date	March 31, 2024		December 31, 2023
Fixed rate mortgage notes payable	4.6%	2025 to 2045	$	418,275	$	492,998
Variable rate mortgage notes payable (1)	6.3%	2026 to 2029	162,114		137,320
Notes payable - insurance	6.3%	2024	854		1,846
Notes payable - other	8.5%	2024	1,213		1,619
Notes payable			$	582,456	$	633,783
Deferred loan costs, net			4,358		4,361
Total notes payable, net of deferred loan costs			$	578,098	$	629,422
Current portion of notes payable			6,831		42,323
Long-term notes payable, net			$	571,267	$	587,099

_____________

(1) See Note 14 for interest rate cap agreements on variable rate mortgage notes payable.

Schedule of Aggregate Scheduled Maturities of Notes Payable

The following schedule summarizes our notes payable as of March 31, 2024 (in thousands):


Principal payments due in:
2024	$	8,075
2025	31,434
2026	335,214
2027	3,597
2028	3,719
Thereafter	200,417
Total notes payable, excluding deferred loan costs	$	582,456

Revenue (Tables)

3 Months Ended

Mar. 31, 2024

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

Revenue for the three months ended March 31, 2024 and 2023 is comprised of the following components (in thousands):


	Three Months Ended March 31,
		2024		2023
Housing and support services		$	59,984	$	53,791
Community fees		459		479
Ancillary services		294		273
Other operating revenue (1)		—		2,063
Resident revenue		60,737		56,606
Management fees		594		505
Managed community reimbursement revenue		6,107		4,962
Total revenues		$	67,438	$	62,073

__________

Net Income Per Share (Tables)

3 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Schedule of Computation of Basic and Diluted Net Income Per Share

The following table sets forth the computation of basic and diluted net income per share (in thousands, except for per share amounts):


	Three Months Ended March 31,
		2024		2023
Basic net income per common share calculation:
Net income		$	27,019	$	24,145

Less: Undeclared dividends on Series A Preferred Stock		(1,335)		(1,198)
Less: Undistributed earnings allocated to participating securities		(2,849)		(3,182)
Net income attributable to common stockholders		$	22,835	$	19,765
Weighted average shares outstanding — basic		9,861		6,855
Basic net income per share		$	2.32	$	2.88

Diluted net income per common share calculation:
Net income attributable to common stockholders		$	22,835	$	19,765
Weighted average shares outstanding — diluted		10,562		7,168
Diluted net income per share		$	2.16	$	2.76

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following weighted-average shares of securities were not included in the computation of diluted net income per common share as their effect would have been antidilutive:


	Three Months Ended March 31,
(shares in thousands)		2024	2023
Warrants		1,031	1,031
Series A Preferred Stock (if converted)		1,230	1,104
Restricted stock awards		22	190

Stock options		10	10
Total		2,293	2,335

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2024

Fair Value Disclosures [Abstract]

Schedule of Carrying Amounts and Fair Values of Financial Instruments


	March 31, 2024				December 31, 2023
	Carrying Amount		Fair Value		Carrying Amount		Fair Value


Cash and cash equivalents	$	24,211	$	24,211	$	4,082	$	4,082
Restricted cash	13,452		13,452		13,668		13,668
Notes payable, excluding deferred loan costs	$	582,456	$	538,271	$	633,783	$	597,266

Derivatives and Hedging (Tables)

3 Months Ended

Mar. 31, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments in the Balance Sheets

The following table presents the fair values of derivative assets and liabilities in the condensed consolidated balance sheets (in thousands):


	March 31, 2024
	Derivative Asset				Derivative Liability
	Notional Amount		Fair Value		Notional Amount		Fair Value

Interest rate cap (SOFR-based)	$	112,955	$	2,130	$	—	$	—
Total derivatives, net	$	112,955	$	2,130	$	—	$	—


	December 31, 2023
	Derivative Asset				Derivative Liability
	Notional Amount		Fair Value		Notional Amount		Fair Value

Interest rate cap (SOFR-based)	$	138,385	$	2,103	$	—	$	—
Total derivatives, net	$	138,385	$	2,103	$	—	$	—

Schedule of Derivative Instruments in the Statement of Operations

The following table presents the effect of the derivative instruments on the condensed consolidated statements of operations (in thousands):



	Three months ended March 31,
		2024		2023
Derivative not designated as hedge
Interest rate cap
Loss on derivatives not designated as hedges included in interest expense		$	(527)	$	(572)

Basis of Presentation (Details) resident in Thousands	Mar. 31, 2024 resident seniorHousingCommunity state
Real Estate Properties [Line Items]
Number of senior housing communities	71
Number of states with senior housing communities \| state	18
Aggregate capacity of residents in senior housing communities \| resident	8
Wholly Owned Properties
Real Estate Properties [Line Items]
Number of senior housing communities	61
Managed On Behalf Of Third Parties
Real Estate Properties [Line Items]
Number of senior housing communities	10

Liquidity (Details) - USD ($) $ in Millions		1 Months Ended
Liquidity (Details) - USD ($) $ in Millions	Apr. 05, 2024	Apr. 30, 2024
Subsequent Event \| ATM Sales Agreement
Subsidiary or Equity Method Investee [Line Items]
Proceeds from sale of stock under agreement	$ 10.3	$ 10.3

Summary of Significant Accounting Policies - Schedule of Cash and Cash Equivalents and Restricted Cash (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022
Restricted Cash and Cash Equivalents Items [Line Items]
Cash and cash equivalents	$ 24,211	$ 4,082
Restricted cash	13,452	13,668
Total cash, cash equivalents, and restricted cash	37,663	17,750	$ 25,146	$ 30,742
Property tax and insurance reserves
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted cash	5,339	7,237
Lender reserves
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted cash	4,665	3,329
Capital expenditures reserves
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted cash	2,714	2,060
Escrow deposit
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted cash	500	1,000
Deposits pursuant to outstanding letters of credit
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted cash	42	42
Other reserves
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted cash	$ 192	$ 0

Summary of Significant Accounting Policies - Narrative (Detail)			3 Months Ended
	Mar. 31, 2024 USD ($) property seniorHousingCommunity	Feb. 02, 2024 USD ($)	Mar. 31, 2024 USD ($) property seniorHousingCommunity segment	Mar. 31, 2023 USD ($) seniorHousingCommunity	Dec. 31, 2023 USD ($)
Accounting Policies [Line Items]
Non-cash impairment charge on property and equipment			$ 0	$ 0
Number of communities \| seniorHousingCommunity			22	24
Grants receivables			$ 0	$ 2,000,000
Resident receivables due period			30 days
Allowance for doubtful accounts	$ 5,700,000		$ 5,700,000		$ 5,300,000
Number of senior housing communities \| seniorHousingCommunity	71		71
Gain on extinguishment of debt, net			$ 38,148,000	$ 36,339,000
Percentage of voting rights	0.50		0.50		0.50
Increase in carrying amount of redeemable preferred stock	$ 1,300,000
Number of reportable segments \| segment			1
Number of operating segments \| segment			1
Protective Life Insurance Company
Accounting Policies [Line Items]
Gain on extinguishment of debt, net		$ 38,100,000
Properties \| Geographic Concentration Risk \| Texas
Accounting Policies [Line Items]
Concentration risk percentage			23.00%
Number of senior housing communities \| property	16		16
Properties \| Geographic Concentration Risk \| Indiana
Accounting Policies [Line Items]
Concentration risk percentage			19.00%
Number of senior housing communities \| property	12		12
Properties \| Geographic Concentration Risk \| Ohio
Accounting Policies [Line Items]
Concentration risk percentage			20.00%
Number of senior housing communities \| property	10		10
Properties \| Geographic Concentration Risk \| Wisconsin
Accounting Policies [Line Items]
Concentration risk percentage			10.00%
Number of senior housing communities \| property	8		8
Convertible Preferred Stock
Accounting Policies [Line Items]
Increase in carrying amount of redeemable preferred stock			$ 1,300,000
Housing and support services
Accounting Policies [Line Items]
Contract liabilities for deferred fees paid	$ 4,300,000		$ 4,300,000		$ 4,000,000
Medicaid Program Revenue \| Revenue Benchmark \| Customer Concentration Risk
Accounting Policies [Line Items]
Concentration risk percentage			11.60%	9.30%

Property and Equipment, net - Schedule of Net Property and Equipment and Leasehold Improvements (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 981,203	$ 977,688
Less accumulated depreciation and amortization	(399,301)	(389,509)
Total property and equipment, net	581,902	588,179
Finance lease, right-of-use asset, after accumulated amortization	$ 100	$ 100
Finance lease, right-of-use asset, statement of financial position	Total property and equipment, net	Total property and equipment, net
Land
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 46,806	$ 47,173
Land improvements
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 20,621	20,487
Land improvements \| Minimum
Property, Plant and Equipment [Line Items]
Asset Lives	5 years
Land improvements \| Maximum
Property, Plant and Equipment [Line Items]
Asset Lives	20 years
Buildings and building improvements
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 848,055	845,873
Buildings and building improvements \| Minimum
Property, Plant and Equipment [Line Items]
Asset Lives	10 years
Buildings and building improvements \| Maximum
Property, Plant and Equipment [Line Items]
Asset Lives	40 years
Furniture and equipment
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 59,081	58,443
Furniture and equipment \| Minimum
Property, Plant and Equipment [Line Items]
Asset Lives	5 years
Furniture and equipment \| Maximum
Property, Plant and Equipment [Line Items]
Asset Lives	10 years
Automobiles
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 2,696	2,687
Automobiles \| Minimum
Property, Plant and Equipment [Line Items]
Asset Lives	5 years
Automobiles \| Maximum
Property, Plant and Equipment [Line Items]
Asset Lives	7 years
Assets under financing leases and leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 3,361	2,766
Construction in progress
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 583	$ 259

Property and Equipment, net - Narrative (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Property, Plant and Equipment [Abstract]
Impairments on long-lived assets	$ 0	$ 0

Accrued Expenses - Schedule of accounts payable and accrued liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Financing Receivable, Modified [Line Items]
Accrued payroll and employee benefits	$ 16,721	$ 15,639
Accrued interest	9,194	11,316
Accrued taxes	5,489	7,614
Accrued professional fees	5,625	5,022
Accrued other expenses	2,718	2,797
Total accrued expenses	39,747	42,388
Entity Loan Modification Program
Financing Receivable, Modified [Line Items]
Accrued interest	$ 5,900	$ 4,300

Notes Payable - Schedule of Notes Payable (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Notes payable	$ 582,456	$ 633,783
Deferred loan costs, net	4,358	4,361
Total notes payable, net of deferred loan costs	578,098	629,422
Current portion of notes payable	6,831	42,323
Long-term notes payable, net	$ 571,267	587,099
Fixed rate mortgage notes payable
Debt Instrument [Line Items]
Weighted average interest rate	4.60%
Notes payable	$ 418,275	492,998
Variable rate mortgages note payable
Debt Instrument [Line Items]
Weighted average interest rate	6.30%
Notes payable	$ 162,114	137,320
Notes payable - insurance
Debt Instrument [Line Items]
Weighted average interest rate	6.32%
Notes payable	$ 854	1,846
Total notes payable, net of deferred loan costs	$ 900
Notes payable - other
Debt Instrument [Line Items]
Weighted average interest rate	8.50%
Notes payable	$ 1,213	$ 1,619

Notes Payable - Schedule of Aggregate Scheduled Maturities of Notes Payable (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Debt Disclosure [Abstract]
2024	$ 8,075
2025	31,434
2026	335,214
2027	3,597
2028	3,719
Thereafter	200,417
Total notes payable, excluding deferred loan costs	$ 582,456	$ 633,783

Notes Payable - Narrative (Details) $ in Thousands							1 Months Ended	3 Months Ended
Notes Payable - Narrative (Details) $ in Thousands	Jun. 01, 2024 USD ($)	Feb. 02, 2024 USD ($) property	Dec. 01, 2023 USD ($)	Jun. 29, 2023 USD ($) property	May 11, 2023 USD ($)	Mar. 01, 2022 USD ($)	Jul. 31, 2023 USD ($)	Mar. 31, 2024 USD ($) property seniorHousingCommunity	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)	Jan. 31, 2023 property	Jul. 31, 2020 property
Debt Instrument [Line Items]
Property and equipment, net								$ 565,500
Repayments of notes payable								41,999	$ 3,714
Gain on extinguishment of debt								38,148	36,339
Deferred loan costs paid								$ 549	0
Number of properties \| seniorHousingCommunity								71
Purchase of interest rate cap								$ 554	$ 0
Derivative, notional amount								112,955		$ 138,385
Notes payable								582,456		633,783
Protective Life Insurance Company
Debt Instrument [Line Items]
Repayments of notes payable		$ 40,200
Debt instrument, repurchase amount		$ 74,400
Number of properties covered under loan \| property		7
Reduction in notes payable		$ 49,600
Gain on extinguishment of debt		$ 38,100
Ally Bank
Debt Instrument [Line Items]
Number of properties covered under loan \| property		6
Increase in principal		$ 24,800
Debt issuance costs, net		500
Interest Rate Cap
Debt Instrument [Line Items]
Debt instrument, variable rate at period end			2.25%				2.25%
Purchase of interest rate cap		600	$ 2,400				$ 2,300
Derivative term			12 months			24 months	1 year
Derivative, notional amount		24,800	$ 88,100			$ 50,300	$ 88,100	$ 112,955		138,385
Interest Rate Cap \| Ally Bank
Debt Instrument [Line Items]
Deferred loan costs paid		$ 600
Forbearance Agreements
Debt Instrument [Line Items]
Debt instrument, weighted average rate								0.015
Forbearance Agreements \| Forecast
Debt Instrument [Line Items]
Debt periodic principal payments	$ 5,000
Fannie Mae Loan \| Fannie Mae
Debt Instrument [Line Items]
Number of properties \| property											2,000
Fannie Mae Loan \| Forbearance Agreements
Debt Instrument [Line Items]
Number of properties \| property				37				37				18
Debt periodic principal payments							$ 5,000
Finance agreement term								12 months
Effective date								1 year
Fannie Mae Loan \| Forbearance Agreements \| Master Credit Facility
Debt Instrument [Line Items]
Number of properties \| property								19
Debt instrument, effective date								36 months
Finance agreement term								12 months
Escrow percentage								0.50
Fannie Mae Loan \| Forbearance Agreements \| Forecast
Debt Instrument [Line Items]
Debt periodic principal payments	$ 5,000
Finance agreement term	24 months
Guaranty amount	$ 10,000
Ally Loan, Amendment \| Forbearance Agreements
Debt Instrument [Line Items]
Debt instrument, covenant, liquidity, amount, minimum				$ 13,000
Debt instrument covenant term				12 months
Limited payment guaranty waiver threshold								$ 6,000
Waiver principal reserve								$ 117
Fixed rate mortgage notes payable
Debt Instrument [Line Items]
Weighted average interest rate								4.60%
Notes payable								$ 418,275		492,998
Fixed rate mortgage notes payable \| Fannie Mae Loan \| Forbearance Agreements
Debt Instrument [Line Items]
Number of properties \| property								18			18
Fixed rate mortgage notes payable \| Minimum
Debt Instrument [Line Items]
Debt effective interest rate								3.60%
Fixed rate mortgage notes payable \| Maximum
Debt Instrument [Line Items]
Debt effective interest rate								6.30%
Variable rate mortgages note payable
Debt Instrument [Line Items]
Debt instrument, variable rate at period end								5.30%
Weighted average interest rate								6.30%
Notes payable								$ 162,114		137,320
Variable rate mortgages note payable \| Minimum
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate								2.14%
Variable rate mortgages note payable \| Maximum
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate								3.50%
Mortgage debt \| Ally Loan, Amendment \| Refinance Facility
Debt Instrument [Line Items]
Increase in principal					$ 1,000
Debt instrument, covenant, liquidity, amount, minimum					$ 7,000
Notes payable - insurance
Debt Instrument [Line Items]
Finance agreement term								10 months
Weighted average interest rate								6.32%
Notes payable								$ 854		1,846
Notes payable - insurance \| Insurance Notes Payable, issued 2023
Debt Instrument [Line Items]
Finance agreement amount										3,300
Notes payable - insurance \| Minimum
Debt Instrument [Line Items]
Stated interest rate								6.25%
Notes payable - insurance \| Maximum
Debt Instrument [Line Items]
Stated interest rate								6.50%
Notes payable - other
Debt Instrument [Line Items]
Weighted average interest rate								8.50%
Notes payable								$ 1,213		$ 1,619

Securities Financing (Detail) - USD ($) $ / shares in Units, $ in Millions				3 Months Ended
	Mar. 31, 2024	Feb. 01, 2024	Jun. 29, 2023	Mar. 31, 2024	Mar. 21, 2024	Dec. 31, 2023	Nov. 30, 2021
Class of Stock [Line Items]
Common stock, shares authorized (in shares)	30,000,000			30,000,000	30,000,000	15,000,000
Temporary equity, shares issued (in shares)	41,000			41,000		41,000
Preferred stock, dividend rate, percentage				11.00%
Increase in carrying amount of redeemable preferred stock	$ 1.3
Preferred stock liquidation preference	8.6			$ 8.6
Mortgage debt
Class of Stock [Line Items]
Purchase commitment value	$ 3.5		$ 13.5	3.5
Commitment period			18 months
Common Stock \| Private Placement
Class of Stock [Line Items]
Shares issued under agreement (in shares)		5,026,318
Price per share of stock sold (in USD per share)		$ 9.50
Common Stock \| Private Placement, Tranche One
Class of Stock [Line Items]
Shares issued under agreement (in shares)		3,350,878
Proceeds from sale of stock under agreement		$ 31.8
Common Stock \| Private Placement, Tranche Two
Class of Stock [Line Items]
Shares issued under agreement (in shares)	1,675,440
Proceeds from sale of stock under agreement	$ 15.9
Convertible Preferred Stock
Class of Stock [Line Items]
Temporary equity, shares issued (in shares)							41,250
Increase in carrying amount of redeemable preferred stock				1.3
Convertible Preferred Stock \| Private Placement
Class of Stock [Line Items]
Proceeds from sale of stock under agreement				$ 41.3

Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
Revenue (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue [Line Items]
Revenues	$ 67,438	$ 62,073
Resident revenue
Disaggregation of Revenue [Line Items]
Revenues	60,737	56,606
Housing and support services
Disaggregation of Revenue [Line Items]
Revenues	59,984	53,791
Community fees
Disaggregation of Revenue [Line Items]
Revenues	459	479
Ancillary services
Disaggregation of Revenue [Line Items]
Revenues	294	273
Other operating revenue
Disaggregation of Revenue [Line Items]
Revenues	0	2,063
Management fees
Disaggregation of Revenue [Line Items]
Revenues	594	505
Managed community reimbursement revenue
Disaggregation of Revenue [Line Items]
Revenues	$ 6,107	$ 4,962

Net Income Per Share - Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Basic net income per common share calculation:
Net income	$ 27,019	$ 24,145
Less: Undeclared dividends on Series A Preferred Stock	(1,335)	(1,198)
Less: Undistributed earnings allocated to participating securities	(2,849)	(3,182)
Net income attributable to common stockholders	$ 22,835	$ 19,765
Weighted average shares outstanding — basic (in shares)	9,861	6,855
Basic net income per share (in USD per share)	$ 2.32	$ 2.88
Diluted net income per common share calculation:
Net income attributable to common stockholders	$ 22,835	$ 19,765
Weighted average shares outstanding — diluted (in shares)	10,562	7,168
Diluted net income per share (in USD per share)	$ 2.16	$ 2.76

Net Income Per Share- Antidilutive (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares excluded from earnings per share (in shares)	2,293	2,335
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares excluded from earnings per share (in shares)	1,031	1,031
Series A Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares excluded from earnings per share (in shares)	1,230	1,104
Restricted stock awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares excluded from earnings per share (in shares)	22	190
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares excluded from earnings per share (in shares)	10	10

Stock-Based Compensation (Detail) - USD ($) $ in Millions	3 Months Ended
Stock-Based Compensation (Detail) - USD ($) $ in Millions	Mar. 31, 2024	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Stock-based compensation expense	$ 0.6	$ 0.9

Commitments and Contingencies (Details) $ in Millions	Mar. 31, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Contractual obligation	$ 3.1

Related Party Transactions (Details) $ in Millions	3 Months Ended
Related Party Transactions (Details) $ in Millions	Mar. 31, 2024 USD ($) shares
Common Stock \| Conversant Investors
Related Party Transaction [Line Items]
Shares issued under agreement (in shares) \| shares	3,157,895
Proceeds from sale of stock under agreement \| $	$ 30.0
Related Party
Related Party Transaction [Line Items]
Ownership percentage, controlling owners	0.61

Fair Value Measurements - Narrative (Detail) - USD ($)	3 Months Ended
Fair Value Measurements - Narrative (Detail) - USD ($)	Mar. 31, 2024	Mar. 31, 2023	Feb. 02, 2024	Dec. 31, 2023	Dec. 01, 2023	Jul. 31, 2023	Mar. 01, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, notional amount	$ 112,955,000			$ 138,385,000
Derivative assets, fair value	2,130,000			2,103,000
Non-cash impairment charge on property and equipment	0	$ 0
Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-cash impairment charge on property and equipment	0	$ 0
Interest Rate Cap
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, notional amount	112,955,000		$ 24,800,000	138,385,000	$ 88,100,000	$ 88,100,000	$ 50,300,000
Derivative assets, fair value	$ 2,130,000			$ 2,103,000

Fair Value Measurements - Carrying Amounts and Fair Values of Financial Instruments (Detail) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Restricted cash	$ 13,452	$ 13,668
Notes payable, excluding deferred loan costs	578,098	629,422
Carrying Amount
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	24,211	4,082
Restricted cash	13,452	13,668
Notes payable, excluding deferred loan costs	582,456	633,783
Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	24,211	4,082
Restricted cash	13,452	13,668
Notes payable, excluding deferred loan costs	$ 538,271	$ 597,266

Derivatives and Hedging - Narrative (Details) - USD ($) $ in Thousands				1 Months Ended	3 Months Ended
	Feb. 02, 2024	Dec. 01, 2023	Mar. 01, 2022	Jul. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Jun. 30, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, notional amount					$ 112,955		$ 138,385
Purchase of interest rate cap					554	$ 0
Interest Rate Cap
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, notional amount	$ 24,800	$ 88,100	$ 50,300	$ 88,100	$ 112,955		$ 138,385
Derivative term		12 months	24 months	1 year
Derivative, cap interest rate		2.25%
Debt instrument, variable rate at period end		2.25%		2.25%
Purchase of interest rate cap	$ 600	$ 2,400		$ 2,300
LIBOR \| Interest Rate Cap
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, cap interest rate			4.00%
SOFR \| Interest Rate Cap
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, cap interest rate								4.00%

Derivatives and Hedging - Schedule of Derivative Instruments in Balance Sheet (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Feb. 02, 2024	Dec. 31, 2023	Dec. 01, 2023	Jul. 31, 2023	Mar. 01, 2022
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, notional amount	$ 112,955		$ 138,385
Derivative assets, fair value	2,130		2,103
Interest Rate Cap
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, notional amount	112,955	$ 24,800	138,385	$ 88,100	$ 88,100	$ 50,300
Derivative assets, fair value	$ 2,130		$ 2,103

Derivatives and Hedging - Schedule of Derivative Instruments in Statement of Operations (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Interest Rate Cap \| Interest Expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Loss on derivatives not designated as hedges included in interest expense	$ (527)	$ (572)

Subsequent Events (Details) $ / shares in Units, shares in Thousands, $ in Thousands						1 Months Ended		3 Months Ended
	May 09, 2024 USD ($)	Apr. 05, 2024 USD ($) $ / shares shares	Feb. 02, 2024 USD ($)	Dec. 01, 2023 USD ($)	Mar. 01, 2022 USD ($)	Apr. 30, 2024 USD ($)	Jul. 31, 2023 USD ($)	Mar. 31, 2024 USD ($) seniorHousingCommunity	Mar. 31, 2023 USD ($)	Jun. 01, 2024 seniorHousingCommunity	Apr. 01, 2024 USD ($)	Dec. 31, 2023 USD ($)
Subsequent Event [Line Items]
Derivative, notional amount								$ 112,955				$ 138,385
Purchase of interest rate cap								$ 554	$ 0
Number of senior housing communities \| seniorHousingCommunity								71
Managed On Behalf Of Third Parties
Subsequent Event [Line Items]
Number of senior housing communities \| seniorHousingCommunity								10
Interest Rate Cap, One
Subsequent Event [Line Items]
Derivative, notional amount			$ 24,800	$ 88,100	$ 50,300		$ 88,100	$ 112,955				$ 138,385
Purchase of interest rate cap			$ 600	$ 2,400			$ 2,300
Derivative term				12 months	24 months		1 year
Derivative, cap interest rate				2.25%
Subsequent Event
Subsequent Event [Line Items]
ATM sales agreement, offering price (up to)											$ 75,000
ATM sales agreement, commission (up to)											3.00%
Subsequent Event \| Macedonia Asset Acquisition
Subsequent Event [Line Items]
Asset acquisition, consideration transferred	$ 10,700
Subsequent Event \| Mortgage debt
Subsequent Event [Line Items]
Note principal amount	9,400
Subsequent Event \| Forecast \| Managed On Behalf Of Third Parties
Subsequent Event [Line Items]
Number of senior housing communities \| seniorHousingCommunity										3
Subsequent Event \| Interest Rate Cap, One
Subsequent Event [Line Items]
Derivative, notional amount						$ 49,200
Purchase of interest rate cap						$ 1,100
Derivative term						24 months
Derivative, basis spread on variable rate						4.00%
Derivative, cap interest rate						4.00%
Subsequent Event \| Interest Rate Cap, Two
Subsequent Event [Line Items]
Derivative, notional amount	9,400
Purchase of interest rate cap	$ 200
Derivative term	24 months
Derivative, basis spread on variable rate	6.00%
ATM Sales Agreement \| Subsequent Event
Subsequent Event [Line Items]
Shares issued under agreement (in shares) \| shares		382
Price per share of stock sold (in USD per share) \| $ / shares		$ 27.50
Proceeds from sale of stock under agreement		$ 10,300				$ 10,300
Stock issuance costs paid		$ 200

Grafico Azioni Sonida Senior Living (NYSE:SNDA)
Storico
Da Ott 2024 a Nov 2024

Clicca qui per i Grafici di Sonida Senior Living

Grafico Azioni Sonida Senior Living (NYSE:SNDA)
Storico
Da Nov 2023 a Nov 2024

SNDA Sonida Senior Living

Notizie Sonida Senior Living - SNDA

La tua Cronologia

Più Attivi

Toplist

SNDA Sonida Senior Living

Notizie Sonida Senior Living - SNDA

La tua Cronologia